Fact-checked by Grok 2 weeks ago

Trans

Transgender, often abbreviated as trans, refers to individuals whose internal sense of their gender differs from their biological sex, which is binary and determined by the production of small gametes (sperm) in males or large gametes (ova) in females, along with associated reproductive anatomy and secondary sex characteristics.^[1]^[2] This incongruence can manifest as gender dysphoria, a condition of clinically significant distress recognized in diagnostic manuals, though its causes remain incompletely understood and appear influenced by a combination of biological anomalies, comorbid mental health issues, and social factors such as peer influence rather than a fixed, innate cross-sex identity.^[3]^[4]^[5] Rates of transgender identification have increased substantially in recent years, particularly among youth, with approximately 1.3 million adults (0.5% of the U.S. population) and 3.3% of high school students self-reporting as transgender, amid a fivefold rise in recorded cases in UK primary care from 2000 to 2018.^[6]^[7]^[8] This surge has fueled debates over potential social contagion, especially in adolescent females, and prompted scrutiny of medical interventions like puberty blockers, cross-sex hormones, and surgeries, which a major independent review found to rest on low-quality evidence with weak support for benefits in minors and risks including infertility, bone density loss, and uncertain impacts on mental health.^[9]^[10] Key controversies include high rates of comorbid conditions like autism, depression, and trauma among those seeking transitions; elevated post-treatment suicide and psychiatric hospitalization risks persisting despite interventions; and detransition, with studies estimating 5-13% of individuals halting or reversing transitions, often citing unresolved underlying issues or external pressures, though true rates may be underreported due to loss to follow-up.^[11]^[12]^[13] Long-term outcomes vary, with some reporting satisfaction and reduced dysphoria but others showing no mitigation of mortality or mental health disparities compared to non-transitioning peers.^[14]^[15] These findings have led to policy shifts, such as restrictions on youth medical transitions in several countries, emphasizing holistic psychological assessment over rapid affirmation.

Biological Reality

Sex Binary in Humans

In humans, biological sex is defined by the type of gamete an individual is organized to produce during their reproductive lifespan: males produce small, mobile gametes (sperm), while females produce large, immobile gametes (ova).^[1]^[16] This dimorphic classification aligns with the anisogamous reproductive strategy observed across sexually reproducing species, where evolutionary pressures favor specialization into two distinct sexes rather than a continuum or additional categories.^[17] No third type of gamete exists in humans or other mammals, precluding the existence of a third sex; claims of a "sex spectrum" often conflate secondary traits or rare developmental anomalies with this foundational binary.^[18] Disorders of sex development (DSDs), formerly termed intersex conditions, represent deviations from typical male or female development but do not constitute evidence against the sex binary. These conditions arise from genetic, hormonal, or environmental disruptions during embryogenesis and typically result in infertility or unambiguous alignment with one sex upon closer examination, rather than a viable intermediate reproductive role.^[16] The prevalence of DSDs with true genital ambiguity—where external genitalia do not clearly indicate male or female—is approximately 0.018% to 0.022% of live births (1 in 4,500 to 5,500), far lower than inflated estimates of 1.7% that include non-reproductive conditions like mild hypospadias or late-onset congenital adrenal hyperplasia, which do not challenge binary sex determination.^[19]^[20] In such cases, individuals are still classified as male or female based on gonadal tissue or potential gamete type, with no documented instances of functional production of both sperm and ova in humans.^[16] Empirical data from genetics, anatomy, and reproductive physiology confirm that approximately 99.98% of humans fit unambiguously within the male-female binary, possessing chromosomal complements (typically XY for males, XX for females), gonads, and ductal systems aligned with one reproductive role.^[21] This near-universality underscores the binary as the normative outcome of mammalian sexual reproduction, where fertilization requires complementary gametes from two sexes, as evidenced by observed human conception rates and evolutionary conservation of dimorphism.^[22] Rare DSDs, while medically significant, function as disorders of sexual development rather than affirmations of fluidity, as they impair rather than expand reproductive categories and occur against the backdrop of binary success in the vast majority of the population.^[23]

Genetic and Chromosomal Basis

In humans, biological sex is primarily determined at fertilization by the chromosomal complement, with females possessing two X chromosomes (46,XX) and males one X and one Y chromosome (46,XY).^[24] The presence of the Y chromosome, specifically the sex-determining region Y (SRY) gene located on its short arm, acts as the master switch for male development. The SRY protein binds to DNA and initiates a cascade leading to testis differentiation around the 6th to 7th week of embryonic development; in its absence, the default pathway results in ovarian development.^[25] ^[26] This binary mechanism is conserved across mammals and underpins the dimorphic reproductive roles, with over 95% of genetic sex determination aligning with this XX/XY paradigm in population studies.^[24] Disorders of sex development (DSDs) represent rare exceptions that underscore the system's robustness rather than undermine it. For instance, Swyer syndrome (46,XY complete gonadal dysgenesis) typically arises from mutations in the SRY gene, preventing testis formation and leading to streak gonads, female external genitalia, and absence of functional gametes; affected individuals cannot produce sperm or viable eggs without medical intervention, confirming the Y chromosome's directive role.^[27] ^[28] Similarly, complete androgen insensitivity syndrome (CAIS) in 46,XY individuals results from mutations in the androgen receptor gene (AR), causing resistance to testicular androgens; this yields female-appearing external genitalia but internal testes, no uterus or ovaries, and infertility, as the chromosomal and gonadal sex preclude female reproductive capacity.^[29] ^[30] In 46,XX congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, excess adrenal androgens masculinize external genitalia prenatally, but internal structures remain female (uterus, ovaries), with no capacity for spermatogenesis or male reproduction; fertility as females is possible post-treatment in milder cases.^[31] ^[32] These conditions affect approximately 1 in 20,000-50,000 births for CAIS and Swyer syndrome, yet none enable reproduction in the opposite sex's functional role, highlighting that DSDs disrupt downstream pathways without altering the foundational chromosomal trigger.^[30] Sex-linked genetic traits exhibit stability post-embryonic gonadal differentiation, as the karyotype is fixed at conception and no natural mechanisms exist to reprogram XX to XY or vice versa in somatic cells.^[24] Genome-wide association studies and transcriptomic analyses confirm that sex-biased gene expression, including dosage compensation via X-inactivation in XX cells and Y-linked genes in XY cells, is established early and persists invariantly through development, resisting postnatal alteration due to the absence of homologous recombination between X and Y chromosomes.^[24] Empirical data from longitudinal genomic profiling show no verified instances of karyotypic sex reversal in humans beyond embryonic stages, with traits like gamete production remaining tied to original chromosomal sex despite hormonal or surgical interventions.^[33] This immutability reflects causal primacy of chromosomal determinants over secondary modifiers, as evidenced by the failure of DSD cases to achieve cross-sex reproductive functionality.^[34]

Reproductive Dimorphism

Human reproductive dimorphism encompasses the morphological, physiological, and functional differences between males and females that arise primarily from genetic and hormonal influences during development, optimized for distinct reproductive roles: sperm production and delivery in males, and ova production, gestation, and lactation in females.^[35] Primary reproductive organs differ fundamentally, with males possessing testes for spermatogenesis, seminal vesicles, and a prostate gland that contributes to semen composition, while females have ovaries for oogenesis, fallopian tubes for ovum transport, and a uterus for embryonic implantation and development.^[36] These structures are determined by the presence or absence of the SRY gene on the Y chromosome, leading to gonadal differentiation around weeks 6-7 of gestation.^[36] Secondary sexual characteristics further accentuate dimorphism, driven by sex hormones post-puberty. Circulating testosterone levels in adult males average 10-35 times higher than in females, typically 300-1000 ng/dL versus 15-70 ng/dL, promoting greater skeletal muscle mass (males possess approximately 40% more lean body mass) and bone density.^[37]^[38]^[39] Skeletal differences include male advantages in height (average 10-15 cm taller globally), broader shoulders, narrower pelvis, and thicker cranial bones, contrasted with female adaptations like a wider pelvic inlet for childbirth and higher body fat distribution for energy reserves during pregnancy.^[35]^[40] These traits reflect evolutionary pressures: male dimorphism linked to intra-sexual competition and provisioning, female to fetal support and offspring survival.^[35] Such dimorphism has causal implications for health outcomes, necessitating sex-specific medical approaches. Females face higher prevalence of autoimmune disorders (affecting 78% of cases, with ratios up to 4:1 female-to-male), attributed to estrogen-modulated immune responses and X-chromosome dosage effects.^[41]^[42] Males, conversely, exhibit elevated risks for conditions like cardiovascular disease and certain injuries, tied to androgen-driven muscle and risk behaviors.^[43] Hormone therapy or surgical interventions do not fundamentally alter these innate dimorphic features, as skeletal structure, chromosomal sex, and core reproductive physiology (e.g., gamete type) remain fixed after developmental windows, with cross-sex hormones yielding only partial, superficial changes in secondary traits like muscle mass or fat distribution.^[43]^[35] This persistence underscores the binary optimization of human dimorphism for species reproduction, independent of later modifications.^[44]

Gender Dysphoria

Definition and Diagnosis

Gender dysphoria is clinically defined as a condition characterized by a marked incongruence between an individual's experienced or expressed gender and their assigned sex at birth, accompanied by clinically significant distress or impairment in social, occupational, or other important areas of functioning.^[45] According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published by the American Psychiatric Association in 2013, the diagnosis requires this incongruence to persist for at least six months and manifest in at least two of the following: a strong desire to eliminate one's primary or secondary sex characteristics due to the mismatch; a desire for the sex characteristics of the opposite sex; a wish to be of the opposite sex; a desire for sex reassignment; a preference for cross-sex roles, clothing, or fantasies; or a conviction that one's feelings align with the opposite sex rather than the assigned sex.^[46] The criteria explicitly emphasize distress or functional impairment as essential, distinguishing the diagnosis from mere gender nonconformity or identity assertion without suffering.^[45] The DSM-5 further specifies that gender dysphoria must not be attributable to a cultural or religious value system, a disorder of sex development, or another mental health condition, such as body dysmorphic disorder (BDD), unless comorbid.^[45] In contrast to BDD, where distress arises from a distorted perception of minor or imagined physical defects leading to repetitive behaviors like mirror checking or avoidance, gender dysphoria involves no such perceptual distortion but rather a targeted incongruence with sex-specific traits without delusional beliefs about their existence.^[46] Diagnosis requires clinical evaluation to exclude these alternatives, as BDD involves preoccupation with appearance flaws not better explained by body image concerns in an eating disorder or gender dysphoria. Internationally, the World Health Organization's International Classification of Diseases, Eleventh Revision (ICD-11), effective from 2022, classifies the condition as "gender incongruence" under sexual health conditions rather than mental disorders, defined as a marked and persistent mismatch between experienced gender and assigned sex, without a mandatory requirement for distress.^[47] This shift from prior ICD versions, which included "gender identity disorder" with a dysphoria component, aims to reduce stigma but has drawn criticism for potentially broadening the category beyond cases of verifiable suffering, as it omits the DSM-5's impairment criterion.^[47] Despite this, clinical practice in many regions retains emphasis on dysphoric distress for intervention thresholds, aligning more closely with DSM-5 standards.^[48]

Prevalence and Demographics

The lifetime prevalence of gender dysphoria in adults is estimated at 0.005-0.014% among biological males and 0.002-0.003% among biological females, according to DSM-5-TR criteria.^[49]^[50] These figures derive from clinical diagnoses and reflect persistent cases meeting diagnostic thresholds for marked incongruence between experienced gender and biological sex, accompanied by distress or impairment.^[51] In adult cohorts seeking treatment, biological males have historically predominated, with male-to-female presentations outnumbering female-to-male by ratios of approximately 2:1 to 4:1 in European and North American clinics prior to the 2010s.^[52] Among adolescents and youth, patterns differ, with recent clinic data showing a reversal: female referrals now exceed male ones, often by ratios exceeding 2:1 in specialized services like the UK's Gender Identity Development Service (GIDS).^[53] Referrals to GIDS rose from 97 in 2009 to 2,519 by April 2018, marking a more than 25-fold increase concentrated in adolescent females.^[54] Gender dysphoria shows notable comorbidity with autism spectrum disorder (ASD), with ASD diagnoses present in 6-26% of individuals with gender dysphoria compared to 1-2% in the general population.^[55]^[56] This overlap is bidirectional, as evidenced by elevated gender dysphoria rates (up to 0.26%) among those with ASD versus 0.16% in neurotypical peers.^[57] Reported prevalence has varied globally and historically, with lower rates in non-Western contexts prior to the 2010s; for instance, Japan documented rates around 0.0009-0.001%, roughly half those in Western Europe (0.001-0.002%).^[58] In Taiwan, diagnosed cases doubled from 2010 to 2019 for both biological sexes, aligning with broader international uptrends in youth presentations.^[59]^[60]

Etiology and Causes

Twin studies of gender dysphoria indicate moderate heritability, with estimates ranging from 11% to 62% depending on age, sex assigned at birth, and population.^[61]^[62] For instance, a 2022 register-based population study in Sweden found 62% heritability overall, while earlier analyses reported 41% for adolescent females and lower for others.^[61] These findings suggest genetic factors contribute substantially but do not fully explain variance, as non-shared environmental influences also play a role.^[63] Prenatal hormone exposure has been hypothesized as a causal factor, with evidence linking atypical androgen levels to gender dysphoria. Studies propose that elevated prenatal testosterone in natal females or reduced levels in natal males may disrupt typical sex differentiation, potentially contributing to incongruence.^[64] For example, higher maternal first-trimester testosterone has been associated with gender dysphoria alongside traits like autism and non-right-handedness, pointing to a shared biological pathway.^[65] However, direct causal evidence remains indirect, often inferred from proxy measures like digit ratios or animal models of hormone effects on behavior.^[64] Neuroimaging and postmortem studies have explored brain structure differences, such as in the bed nucleus of the stria terminalis (BSTc), where male-to-female individuals showed female-typical volumes in a seminal 1995 study.^[66] Yet, these findings are limited by small sample sizes (often n<10 per group), postmortem confounds like hormone therapy history or sexual orientation biases, and lack of replication in living subjects pre-treatment.^[67] Critics note that BSTc sexual differentiation occurs postnatally, undermining claims of innate "mismatch" as a primary cause, and no consistent brain patterns uniquely predict dysphoria across larger cohorts.^[68] Gender dysphoria exhibits high comorbidity with other mental health conditions, with 40-70% of diagnosed youth showing concurrent depression, anxiety, autism, or trauma-related disorders pre-treatment.^[69]^[70] In clinical samples, over 70% of young people with a gender dysphoria diagnosis had at least one additional psychiatric condition, including 47% with anxiety and substantial overlap with mood disorders.^[70]^[71] This pattern raises questions of underlying psychological vulnerabilities driving dysphoric symptoms rather than isolated gender incongruence, though causation direction remains debated. Persistence of childhood gender dysphoria into adulthood is low without intervention, with follow-up studies reporting desistance rates of 60-90% by adolescence or later.^[72] For example, longitudinal data on clinic-referred boys showed high desistance alongside shifts to non-heterosexual orientations, while broader reviews of pre-pubertal cases confirm 80% resolution by ages 15-16.^[73]^[74] These rates contrast with adolescent-onset cases, fueling debate over innate versus socially influenced origins, particularly amid rapid increases in female adolescent referrals potentially linked to peer networks or online exposure.^[75] Empirical challenges to pure innateness include critiques of "social contagion" hypotheses, but unresolved comorbidities and desistance patterns underscore multifactorial etiology prioritizing biological and psychological realism over socialization primacy.^[76]^[72]

Historical Context

Early Medical Cases

In the 19th century, medical examinations of sex nonconformity occasionally intersected with discoveries of intersex conditions, as exemplified by the case of Herculine Barbin (1838–1868), a French individual raised as female who petitioned to live legally as male in 1860 after public scrutiny of ambiguous physical traits. Barbin's memoirs, published posthumously, described persistent discomfort with assigned female status, but autopsy following suicide revealed ovotestes and internal male reproductive structures, confirming a disorder of sex development rather than psychological gender incongruence alone. German sexologist Magnus Hirschfeld advanced early clinical approaches to cross-gender identification through his 1910 monograph Die Transvestiten, which differentiated "transvestism" (cross-dressing driven by erotic or identity factors) from mere fetishism, based on case studies of over 100 individuals seeking relief from distress. In 1919, Hirschfeld founded the Institute for Sexual Science in Berlin, providing counseling, hormone treatments derived from animal extracts, and rudimentary surgeries for select patients exhibiting profound sex-role inversion, though outcomes were limited by era-specific medical constraints like infection risks. The institute facilitated the earliest documented sex reassignment procedures, including a 1926 mastectomy on a biological female identifying as male, performed by surgeon Felix Abraham under Hirschfeld's auspices, followed by similar interventions on others by 1930. Danish artist Lili Elbe (born Einar Wegener, 1882–1931) underwent a series of experimental surgeries in Dresden clinics between 1930 and 1931, comprising orchiectomy, penectomy, and attempts at vaginoplasty and uterine transplantation using donor tissue; she succumbed to postoperative peritonitis and organ rejection just 18 months after initiating treatment, highlighting the high lethality of pre-antibiotic era procedures.^[77]^[78] Such cases remained exceedingly rare prior to the 1960s, with fewer than a dozen recorded surgical attempts worldwide by mid-century, often conflating transvestism, homosexuality, and intersexuality under pathological rubrics like "sexual inversion" per Krafft-Ebing's 1886 Psychopathia Sexualis. Endocrinologist Harry Benjamin's 1966 book The Transsexual Phenomenon, drawing on 150 patient histories, proposed a sex-orientation scale classifying "true transsexuals" (degrees IV–VI) as distinct entities warranting estrogen/androgen therapy and surgery after psychological evaluation, marking a diagnostic pivot from viewing cross-gender states as curable perversions to chronic mismatches treatable via alignment with self-perception.^[79]^[80]

Rise of Modern Transgender Movement

The Johns Hopkins Hospital established the first dedicated clinic for gender identity issues in the United States in 1966, performing the nation's initial sex reassignment surgeries under the direction of physicians including John Money and Claude Migeon.^[81] The program, which treated a small number of patients over 13 years, aimed to address persistent gender incongruence through surgical and hormonal interventions following psychotherapy failures.^[81] However, a 1979 study by psychiatrist Paul McHugh, who became department chief in 1975, found no evidence of improved mental health or reduced psychopathology post-surgery, likening outcomes to enabling delusion rather than resolving underlying issues, prompting the clinic's abrupt closure that year.^[82]^[83] In 1979, the Harry Benjamin International Gender Dysphoria Association (later renamed the World Professional Association for Transgender Health, or WPATH) was founded to standardize care protocols amid growing clinical interest, releasing its inaugural Standards of Care that outlined hormonal and surgical criteria for gender dysphoric individuals.^[84] These guidelines evolved through subsequent editions, expanding eligibility and incorporating multidisciplinary assessments while emphasizing informed consent and long-term follow-up, though early versions reflected limited empirical data on outcomes.^[84] The association's formation marked a shift toward professionalizing transgender medicine beyond isolated clinics, influencing global practices despite debates over evidence quality.^[78] Diagnostic frameworks in psychiatry also evolved, with the American Psychiatric Association introducing "gender identity disorder" in the Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) published in 1980, categorizing it as a mental disorder involving distress from incongruence between experienced gender and biological sex.^[85] This followed the 1973 removal of homosexuality as a disorder, reflecting broader depathologization trends but retaining a disorder label for gender-related conditions until the DSM-5 in 2013 replaced it with "gender dysphoria" to focus solely on clinically significant distress rather than identity itself, aiming to destigmatize while maintaining access to medical interventions.^[86]^[86] The 1990s saw increased visibility through emerging internet technologies, with platforms like CompuServe's Genderline forum and early email lists such as CDForum enabling transgender individuals, particularly youth, to connect anonymously, share experiences, and explore identities outside isolated medical contexts.^[87] These online spaces, predating widespread social media, fostered community building and self-discovery, correlating with rising referrals to gender clinics as awareness spread beyond elite medical circles to broader populations.^[88] By the 2000s, media portrayals and digital dissemination amplified the movement's cultural presence, transitioning transgender experiences from medical rarity— with clinic caseloads in the dozens annually in the 1960s—to a more visible social phenomenon, though empirical data on prevalence remained sparse until later decades.^[87]

Key Figures and Events

Christine Jorgensen, a former U.S. Army veteran, underwent a series of orchiectomy and penectomy surgeries in Denmark starting in 1950, followed by hormone treatments, becoming one of the first Americans to publicly transition from male to female; her return to the U.S. in 1952 garnered extensive media attention, marking a pivotal moment in public awareness of sex reassignment procedures.^[89]^[90] This publicity highlighted surgical possibilities but also sparked debates on psychological outcomes, as Jorgensen's case emphasized physical transformation amid limited long-term follow-up data on satisfaction rates. Jan Morris, a British journalist and historian born James Morris, published the memoir Conundrum in 1974, detailing her transition including hormone therapy and surgery in 1972; the book provided an introspective account of gender incongruence from a literary perspective, influencing cultural perceptions by framing transition as a personal quest for authenticity rather than a medical anomaly.^[91]^[92] Critics noted its romanticized tone overlooked empirical evidence on etiology, yet it contributed to normalizing narratives of self-identified gender shifts in intellectual circles. Psychiatrist Paul McHugh, appointed chair of psychiatry at Johns Hopkins University in 1975, oversaw the closure of the university's Gender Identity Clinic in 1979 after reviewing follow-up data on postoperative patients, concluding that surgeries did not alleviate underlying mental health issues and akin to enabling delusion rather than resolving distress; this decision, based on a study finding no psychiatric benefits, halted gender-affirming surgeries there for decades and underscored early skepticism toward interventions lacking randomized evidence.^[93]^[94] The Stonewall Riots of June 28, 1969, in New York City, primarily a response to police raids on gay establishments, indirectly advanced transgender visibility through participation by figures like Marsha P. Johnson, galvanizing broader LGBTQ activism that later encompassed gender identity advocacy.^[95] In diagnostic shifts, the American Psychiatric Association's DSM-III in 1980 classified "Gender Identity Disorder" as a mental disorder distinct from homosexuality (depathologized in 1973), enabling clinical focus but inviting critiques for pathologizing nonconformity without causal clarity.^[96] Early desistance research, such as longitudinal studies from the 1980s onward tracking clinic-referred children, reported persistence rates as low as 10-20%, with most resolving dysphoria by adolescence without intervention, informing conservative approaches prioritizing watchful waiting over affirmation.^[73]^[74] The 2015 Supreme Court ruling in Obergefell v. Hodges legalized same-sex marriage nationwide, providing an indirect legal framework boost for transgender individuals by reinforcing nondiscrimination in spousal recognition, though it centered on sexual orientation rather than gender identity claims.^[97]

Medical Interventions

Puberty Blockers

Puberty blockers, primarily gonadotropin-releasing hormone (GnRH) analogs such as leuprolide (Lupron) and triptorelin, function by continuously stimulating GnRH receptors in the pituitary gland, leading to downregulation and subsequent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion.^[98] ^[99] This inhibition halts the hypothalamic-pituitary-gonadal axis, preventing the production of endogenous sex hormones like estrogen and testosterone, thereby arresting pubertal development at Tanner stage 2 or later.^[100] 30099-2/fulltext) Administered via intramuscular injections every 1-3 months, these medications were originally approved for conditions such as precocious puberty but are used off-label for gender dysphoria in adolescents.00686-3/fulltext) ^[101] The application of GnRH analogs for delaying puberty in cases of gender dysphoria emerged in the Netherlands during the late 1980s and early 1990s, formalized in the Dutch protocol developed by clinicians including Peggy Cohen-Kettenis and Henriette Delemarre-van de Waal.^[102] ^[103] This approach targeted adolescents with persistent gender dysphoria since childhood, aiming to pause physical changes to provide time for psychological exploration and informed consent before proceeding to cross-sex hormones.^[104] Early implementation involved small cohorts, such as the 70 adolescents in the foundational Dutch studies published in 2006 and 2011, which reported effective pubertal suppression without immediate reversal upon discontinuation in most cases.^[102] ^[105] Proponents of short-term use argue that blockers offer a reversible window—typically 1-3 years—for decision-making, as puberty resumes if treatment stops, though evidence from these limited cohorts indicates variable reversibility in gonadal function and highlights the experimental nature of the intervention outside precocious puberty contexts.30099-2/fulltext) ^[106] Initial trials, often involving fewer than 100 participants, demonstrated suppression of secondary sex characteristics but lacked randomized controls or large-scale comparisons.^[105] ^[102] Short-term administration has been associated with risks including decreased bone mineral density (BMD), with studies noting stagnation or decline in lumbar spine BMD within 12-24 months, potentially due to the absence of pubertal sex steroid surges critical for skeletal accrual.^[107] ^[108] One prospective cohort observed no BMD change at the spine after 12 months but elevated lumbar BMC and BMD at 24 months relative to baseline, though broader reviews emphasize concerns over impaired peak bone mass accrual even in brief use.^[107] ^[109] These findings, drawn from non-randomized observational data, underscore the trade-offs in suppressing natural pubertal processes.^[110]^[109]

Cross-Sex Hormones

Cross-sex hormone therapy involves the administration of exogenous hormones to induce physiological changes aligning with an individual's identified gender, typically following puberty suppression or after early puberty in adolescents. For transgender males (assigned female at birth), intramuscular or transdermal testosterone is used, with target levels of 300-1000 ng/dL to mimic cisgender male ranges.^[111] Physiological effects include irreversible voice deepening, increased facial and body hair growth, clitoral enlargement (often 1.5-3 cm), cessation of menses within 1-6 months, and gains in muscle mass and strength, with fat redistribution toward the abdomen.^[111]^[112] Acne and male-pattern baldness may occur, alongside elevated hematocrit levels requiring monitoring to prevent polycythemia.^[113] For transgender females (assigned male at birth), regimens combine estrogen (oral, transdermal, or injectable forms, targeting 100-200 pg/mL estradiol) with anti-androgens such as spironolactone or cyproterone acetate to suppress testosterone below 50 ng/dL; progesterone may be added for potential breast maturation, though evidence is limited.^[112]^[114] Induced changes encompass breast development (typically Tanner stage 3-4 after 2-3 years), subcutaneous fat redistribution to hips and thighs, reduced muscle mass, decreased erectile function, and testicular atrophy leading to infertility.^[112] Skin softens and body hair thins, but scalp hair loss may persist if androgenetic alopecia predates treatment.^[114] Therapy initiation in adolescents generally follows Tanner stage 2 of puberty (breast budding or testicular enlargement, around ages 10-12), often after gonadotropin-releasing hormone analogues, to minimize endogenous sex hormone effects while allowing partial pubertal progression.^[115] Fertility preservation is recommended beforehand, including semen cryopreservation for transgender females (effective prior to estrogen, as spermatogenesis declines rapidly) and oocyte or embryo freezing for transgender males (feasible before testosterone, which induces ovarian dysfunction akin to polycystic ovary syndrome).^[116]^[117] Risks necessitate ongoing monitoring: testosterone elevates erythrocytosis (hematocrit >54% in up to 10% of cases) and cardiovascular markers, while estrogen increases venous thromboembolism incidence 2-15-fold compared to cisgender females, particularly with oral formulations due to first-pass liver effects.^[118]^[119] Transdermal estrogen mitigates this risk by avoiding hepatic metabolism.^[120] Bone density and lipid profiles require serial assessment, with dual-energy X-ray absorptiometry scans advised if delays in treatment occur.^[112]

Surgical Procedures

Surgical procedures for transgender individuals, often termed gender-affirming surgeries, encompass modifications to the chest and genitalia to align physical characteristics with gender identity. These interventions originated in the 1960s, with Johns Hopkins Hospital establishing the first U.S. gender identity clinic in 1966, performing initial sex reassignment surgeries under pioneers like John Money and Jonas Salk's influence on intersex cases, though the program closed in 1979 amid debates over efficacy.^[121]^[83] Top surgeries include mastectomy for transmasculine individuals, which removes breast tissue via techniques such as double incision (for larger breasts) or periareolar (for smaller), followed by nipple-areola complex repositioning or grafting, and breast augmentation for transfeminine individuals using silicone implants placed submuscularly or subglandularly. Complication rates for mastectomy are relatively low, with hematoma occurring in 3-4.9%, seroma in 0.7-6%, and infections under 3% in peer-reviewed series.^[122]^[123] Breast augmentation carries risks like capsular contracture (5-10%) and implant rupture (1-2% annually).^[124] Bottom surgeries for transfeminine individuals typically involve vaginoplasty, often penile inversion where penile skin is inverted to form the vaginal canal, with scrotal graft for labia and clitoroplasty from glans tissue; intestinal variants use sigmoid colon for the neovagina. Complication rates are higher, with overall rates up to 33%, including fistulas (2-5%), stenosis (14%), and prolapse (5-10%) in systematic reviews.^[125]^[126] For transmasculine individuals, phalloplasty constructs a neophallus using radial forearm free flap, incorporating urethral lengthening, with metoidioplasty as a less invasive option enlarging clitoral tissue via hormones and release. Phalloplasty exhibits complication rates as high as 76.5% within 30 days, including flap failure (5-10%), urinary fistulas (20-50%), and strictures (15-30%).^[124] Eligibility criteria, as outlined in the World Professional Association for Transgender Health (WPATH) Standards of Care Version 8 (2022), require persistent gender dysphoria, capacity for informed consent, and for genital surgeries, typically 12 continuous months of hormone therapy (unless medically contraindicated) and documented living in the desired gender role, alongside mental health assessment; chest surgeries demand fewer prerequisites, focusing on dysphoria documentation and decision-making capacity.^[127]^[128] Uninsured costs in the U.S. range from $8,500-11,500 for top surgery, $25,000-45,000 for vaginoplasty, and $60,000+ for phalloplasty, often exceeding $100,000 when combining procedures and revisions.^[129]^[130]^[131]

Outcomes of Treatments

Mental Health Improvements and Suicidality

Short-term studies of gender transition interventions, including hormone therapy and surgery, frequently report reductions in self-reported gender dysphoria, with improvements on metrics such as the Utrecht Gender Dysphoria Scale (UGDS) and satisfaction rates often cited at 80-90% within 1-2 years post-treatment.^[132] These outcomes are primarily drawn from prospective cohorts in specialized gender clinics, where participants exhibit high motivation for affirmation.^[133] However, such research often lacks randomized controls, long-term tracking, or adjustment for placebo effects and selection bias, as patients experiencing adverse outcomes may discontinue follow-up.^[15] Despite reported dysphoria relief, overall mental health does not normalize post-transition, with elevated psychiatric morbidity persisting. A 2021 analysis of a large U.S. claims database found that while gender-affirming surgery correlated with lower odds of severe psychological distress in the short term, transgender individuals still required substantially higher rates of mental health treatment compared to cisgender peers, indicating unresolved comorbidities like depression and anxiety.^[134] Systematic reviews highlight methodological weaknesses in affirmative studies, including small samples and confounding from concurrent psychotherapy, which inflate perceived benefits.^[133] Suicidality remains markedly higher after transition, challenging claims of comprehensive mental health gains. The 2011 Dhejne et al. Swedish cohort study followed 324 post-sex reassignment surgery individuals for up to 30 years, documenting suicide attempt rates of 4.9% versus 0.8% in matched controls, and suicide mortality 19.1 times the general population rate; these elevations did not diminish over time.^[135] A 2020 correction to a 2019 Swedish study similarly found no reduction in mental health treatment utilization or suicidality post-surgery, contradicting initial affirmative interpretations.^[15] Recent U.S. data from 2023 confirm transgender adults experience 2-3 times higher all-cause mortality, driven partly by external causes including suicide, even after interventions.^[136] Pre-existing comorbidities, such as mood disorders (prevalent in 40-50% of cases) and autism spectrum traits, often underlie gender dysphoria but receive insufficient targeted treatment in transition-focused protocols, perpetuating vulnerability.^[137] ^[138] Clinic-based studies from affirmative paradigms tend to underreport these factors, as evidenced by high baseline psychiatric diagnoses that persist without holistic intervention.^[139] Independent reviews, including those assessing evidence quality, underscore that causal links between transition and sustained mental health improvements remain unproven, with risks amplified by untreated confounders.^[10]

Regret and Detransition Rates

Reported regret rates following gender-affirming surgeries in clinical studies range from 0.3% to 3.8%, based on pooled data from multiple investigations, though these figures derive primarily from short-term follow-ups and self-selected clinic populations.^[140] A 2023 study of patients post-mastectomy reported a 1% regret rate using standardized instruments, but acknowledged limitations in capturing long-term outcomes beyond 3-5 years.^[141] Systematic reviews of surgical regret similarly cite rates under 1% for gender-affirming procedures, contrasting with higher regret (up to 14%) in elective plastic surgeries, yet note methodological flaws such as incomplete follow-up in affirmative care settings where patients may not return for reversal.^[142] Detransition rates, encompassing discontinuation of hormones or reversal of social/medical transition, are difficult to quantify due to inconsistent tracking and high attrition in longitudinal studies, with over 30% loss to follow-up in some cohorts.^[143] Clinic-based data indicate low discontinuation, such as a 70% four-year hormone continuation rate among adults, but these metrics often exclude those who cease contact with providers.^[144] Self-reported surveys among broader transgender populations reveal higher lifetime detransition experiences, with 13.1% of 17,151 respondents reporting at least one instance, though 82.5% attributed it to external factors like discrimination rather than internal reassessment.^[13] Independent analyses pooling high-reliability studies estimate combined regret and detransition at 2.5-2.7%, with median onset of regret occurring 3-8 years post-treatment, underscoring the inadequacy of short-term clinic reports.^[145] The Cass Review (2024) concluded that detransition and regret rates among youth remain unknown, citing insufficient long-term data and audits showing under 1% in treated cohorts, but emphasizing that affirmative models prioritize continuation over systematic reversal tracking, unlike earlier watchful-waiting approaches with higher pre-treatment desistance.^[10] In Finland, post-2015 increases in adolescent referrals correlated with emerging detransition cases, including a 2024 register study finding discontinuation risks tied to psychiatric comorbidities, though exact proportions were low (e.g., analysis of nine clinic patients highlighted rare but complex reversal pathways involving trauma and misdiagnosis).^[146] Factors contributing to detransition in documented cases include social influences, unresolved mental health issues, and recognition of non-gender-related dysphoria origins, as seen in the 2020 UK High Court case of Keira Bell, who received puberty blockers at 16 and testosterone at 17 before detransitioning at 20 and challenging inadequate informed consent.^[147] Gender clinics' affirmative frameworks, influenced by institutional pressures to affirm identities, often underreport regret by design, as fewer than 25% of detransitioners return to original providers, biasing data toward persistence.^[145] This contrasts with surveys of detransitioner communities, where self-reported regret approaches 10-30% in subsets, though these lack population representativeness and may reflect selection effects.^[148] Long-term empirical scrutiny reveals that while overt regret appears infrequent in followed cohorts, true incidence likely exceeds clinic figures due to untracked dropouts and delayed realizations, particularly amid rising youth-onset cases post-2015.^[145]

Long-Term Physical Effects

Puberty suppression with gonadotropin-releasing hormone analogues (GnRHa) in transgender youth is associated with reductions in bone mineral density (BMD), with longitudinal studies indicating losses of up to 10% or more during treatment, particularly with prolonged use exceeding two years.^[149] A 2022 analysis of adolescents on GnRHa found that longer duration correlated with significantly lower BMD z-scores, failing to fully recover even after initiation of cross-sex hormones.^[150] These deficits arise from halted pubertal bone accrual, a critical period for peak bone mass, potentially elevating fracture risk into adulthood absent compensatory gains.^[106] Cross-sex hormone therapy introduces elevated cardiovascular risks, notably in transgender women receiving estrogen, where meta-analyses report 2- to 5-fold increases in venous thromboembolism (VTE) and ischemic stroke compared to cisgender controls.^[151] Testosterone in transgender men may worsen lipid profiles and arterial stiffness, contributing to higher cardiometabolic burdens, though evidence is mixed on acute events like myocardial infarction.^[152] Long-term cohort data from the Amsterdam clinic, spanning 1972-2015, documented overall mortality rates 1.8 times higher than expected in transgender women, driven partly by cardiovascular disease, with similar patterns persisting despite improved HIV management.00185-6/fulltext) Infertility emerges as a frequent outcome, often permanent, following combined puberty blockade and cross-sex hormones without prior gamete preservation; estrogen suppresses spermatogenesis irreversibly in many transgender women, while prolonged GnRHa in youth impairs gonadal maturation, yielding immature germ cells unlikely to restore fertility post-cessation.^[153] A 2024 Mayo Clinic study of boys on blockers revealed persistent damage to spermatogonial stem cells, suggesting potential irreversibility even after discontinuation.^[154] In transgender men, testosterone induces ovarian dysfunction and atresia, rendering natural conception improbable after years of exposure.^[116] Surgical interventions carry enduring physical risks, including retained prostate tissue in transgender women post-vaginoplasty, which maintains susceptibility to prostate cancer requiring ongoing screening via digital rectal exam or MRI, as the gland is not excised to preserve neovaginal integrity.^[155] A Swedish cohort follow-up of post-surgical transgender individuals (1973-2003) reported 2- to 3-fold elevated overall mortality, including from cardiovascular causes, compared to the general population, with complications like thromboembolism linked to hormone continuation.^[156] Neovaginal tissues face rare but documented oncogenic potential, such as squamous cell carcinoma arising from chronic inflammation or HPV exposure in penile-inversion grafts.^[157]

Gender Identity and Expression

Gender identity is defined as a person's internal, psychological sense of their own gender, which may be male, female, both, neither, or otherwise, independent of biological sex characteristics such as chromosomes, reproductive anatomy, or secondary sexual traits.^[158] This conceptualization, formalized by organizations like the American Psychological Association, posits gender identity as potentially incongruent with one's natal sex, though empirical evidence linking it to measurable biological markers remains limited and contested, with studies often relying on small samples or correlational data rather than causal mechanisms.^[159]^[160] Binary transgender identities involve a self-perception as the opposite sex from one's biological sex, while non-binary identities encompass perceptions of gender as fluid, absent, or outside the male-female binary; the latter has seen reported increases among youth in recent years, though prevalence surveys indicate stabilization or declines as of 2024-2025. In the United States, approximately 1.0% of individuals aged 13 and older identified as transgender (including non-binary) in estimates from 2025, with youth rates historically peaking around 1-2% in self-reports before recent drops, such as non-binary identification among young adults falling by over half from 2022 to 2024 in some generational cohorts.^[161]^[162] These shifts may reflect social contagion effects, as rapid rises in identifications correlated with cultural visibility rather than consistent biological predictors, though longitudinal data is sparse.^[163] Gender expression refers to the external manifestation of gender through behaviors, clothing, mannerisms, and grooming, which individuals may align with their perceived identity rather than biological sex. Such expressions frequently draw on societal stereotypes—femininity via dresses and soft speech, masculinity via suits and assertiveness—prompting critiques that they inadvertently reinforce binary norms by treating these traits as inherently sex-linked, rather than culturally variable or individually chosen irrespective of identity claims.^[158] For instance, transgender individuals often adopt stereotypical presentations to "pass" as the desired sex, which some analysts argue perpetuates the very gender roles purportedly rejected, as non-conformity to norms could suffice without reifying opposites.^[164] Philosophically, contemporary gender identity theory draws from postmodern frameworks, such as Judith Butler's 1990 work Gender Trouble, which argues gender is not an innate essence but a "performativity"—a repeated citation of cultural acts that constructs identity through iteration, lacking fixed biological grounding. This view contrasts with claims of gender identity as an inherent, possibly neurologically wired trait akin to a mismatch between brain and body, advanced by some clinicians and advocates, though supporting research faces methodological critiques for failing to distinguish correlation from causation or account for post-treatment confounds.^[165] Butler's performativity emphasizes subversion of norms over essentialist identities, influencing academic discourse but diverging from first-principles biological realism where sex dimorphism underpins observable traits.^[166]

Media and Arts Representation

In literature, transgender themes have appeared in works exploring identity and transition, such as Leslie Feinberg's Stone Butch Blues (1993), which depicts the life of a gender-nonconforming butch lesbian navigating industrial-era America and medical interventions.^[167] Julia Serano's Whipping Girl (2007) combines memoir and theory to argue against common misconceptions of trans women as deceptive or hyperfeminine.^[167] These texts often emphasize personal resilience amid societal rejection, though critics note they sometimes prioritize activist narratives over broader empirical accounts of dysphoria outcomes.^[168] In music, transgender artists have gained visibility through albums addressing transition experiences, including Wendy Carlos's Switched-On Bach (1968), released after her gender-affirming surgery, which pioneered electronic synthesis without initially disclosing her trans status.^[169] Laura Jane Grace of Against Me! publicly transitioned in 2012, releasing Transgender Dysphoria Blues (2014) to chronicle emotional and physical challenges.^[169] More recent examples include Kim Petras's pop hits like "Unholy" (2022), which earned her a Grammy in 2023 as the first openly trans winner, highlighting commercial success amid genre constraints.^[170] However, trans musicians outside pop and rock remain underrepresented, with many facing barriers to mainstream genres.^[170] Film and television portrayals of transgender individuals have evolved from early stereotypes to more nuanced roles, but persistent tropes include deception and villainy. In a 2002-2012 analysis of U.S. scripted TV, GLAAD found transgender characters depicted as victims in 40% of instances and as killers or villains in 21%, often reducing them to plot devices rather than fully developed persons.^[171] Shows like Pose (2018-2021) offered affirmative depictions of trans women in New York City's ballroom scene, drawing praise for authenticity via trans cast members like MJ Rodriguez.^[172] Conversely, films such as Ace Ventura: Pet Detective (1994) reinforced the "deceptive trans" caricature, portraying trans women as threats through revelation gags.^[168] Casting cisgender actors in trans roles, as in Transparent (2014-2019) with Jeffrey Tambor, has drawn criticism for inauthenticity and limiting opportunities for trans performers.^[173] Recent data indicate fluctuating visibility: GLAAD's 2023-2024 TV report counted 24 transgender characters across series, comprising 5.1% of LGBTQ roles, a decline from prior seasons amid broader reductions in inclusive content.^[174] In major studio films for 2023, only two included trans characters, both featuring stereotypes or inauthentic elements per the organization's analysis.^[175] Achievements include heightened awareness, with studies linking exposure to multiple trans stories to improved public attitudes. Yet critiques highlight overreliance on success narratives, sidelining regrets or detransition—evident in media's infrequent coverage of cases like those documented in peer-reviewed regret studies—potentially skewing perceptions toward uncritical affirmation.^[176]^[177] This selective focus, often from advocacy-influenced sources, contrasts with empirical data on varied transition outcomes.^[168] Social transition refers to non-medical changes in appearance, name, and pronouns to align with a person's identified gender, often initiated in childhood or adolescence before any hormonal or surgical interventions.^[72] These practices include adopting preferred pronouns such as "he," "she," "they," or neopronouns like "xe/xir," alongside clothing and hairstyle modifications to signal the desired gender presentation.^[178] In educational settings, many school districts have adopted policies permitting students to socially transition without mandatory parental notification or consent, allowing changes to official records, restroom access, and peer interactions based on self-reported gender identity.^[179] ^[180] Among gender-dysphoric youth, early social transition has been associated with high rates of persistence in transgender identification. A 2022 analysis of socially transitioned children found that 98% continued to desire medical gender transition after several years, contrasting with historical desistance rates of around 80% in untreated cohorts where gender dysphoria often resolved by adulthood.^[72] Similarly, a study of minors at a Spanish gender clinic reported 97.6% persistence after a median 2.6-year follow-up following social transition elements.^[181] These outcomes suggest social affirmation may reinforce gender incongruence, potentially reducing natural resolution observed in prior longitudinal data without such interventions.^[182] Proponents argue that using preferred pronouns fosters peer acceptance and reduces distress, with surveys indicating lower suicide attempt rates among transgender youth whose pronouns are consistently respected by household members—halving from 19% to 9% in one self-reported sample.^[183] However, such associations are correlational and derived from advocacy-led surveys like those from The Trevor Project, which lack controls for confounding factors such as pre-existing mental health stability or selection bias toward affirming environments.^[184] Critics highlight interpersonal tensions, including debates over compelled speech, where refusal to use preferred pronouns is framed as "misgendering" causing harm like increased anxiety, though causal evidence remains anecdotal or based on subjective reports rather than rigorous trials.^[185] ^[186] This has led to conflicts in social settings, with peer reinforcement of transitions potentially isolating non-conforming individuals and raising concerns about free expression versus accommodation demands.^[187]

Controversies

Youth Gender Dysphoria and Transitioning

Gender dysphoria in children typically manifests before puberty, often alongside other developmental or psychological factors, with longitudinal studies showing persistence rates as low as 10-20% into adolescence without intervention.^[73] Prepubertal desistance rates, where the distress resolves naturally by puberty, have been estimated at 80% or higher across multiple clinic-based follow-ups of referred children, particularly when avoiding early social affirmation of cross-sex identity.^[188] These findings derive from cohorts tracked over years, such as those from specialized gender clinics, where most children realigned with their biological sex post-puberty, though methodological critiques note potential undercounting of persistent cases due to dropout attrition.^[189] In contrast, adolescent-onset gender dysphoria, emerging during or after puberty, exhibits higher persistence, potentially linked to social influences rather than innate cross-sex identification. The rapid-onset gender dysphoria (ROGD) hypothesis, proposed in a 2018 survey-based study of parent reports, describes cases where teens—predominantly natal females—suddenly declare transgender identity without prior childhood indicators, often clustering among friend groups or following online exposure, with 62.5% of respondents noting increased peer social transitioning.^[5] This pattern suggests environmental contagion factors, though the study's reliance on concerned parents introduces selection bias, and subsequent research has debated its generalizability amid ideological pushback in academic publishing.^[75] Medical interventions like puberty blockers and cross-sex hormones for dysphoric youth have been applied in some settings from early adolescence, purportedly to mitigate distress, but systematic reviews highlight scant high-quality evidence for long-term benefits. The 2024 Cass Review, commissioned by the UK's National Health Service, evaluated over 100 studies and found the evidence base for blockers "remarkably weak," with low methodological rigor, unclear impacts on mental health or dysphoria persistence, and risks including bone density loss and fertility impairment, leading to recommendations for non-routine use pending randomized trials.^[10] ^[190] Observational data indicate 92% of blocker recipients progress to hormones within 12-36 months, potentially locking in trajectories amid unresolved comorbidities like autism or trauma.^[191] Therapeutic approaches diverge sharply: gender-affirmative models prioritize immediate validation and transition to supposedly reverse dysphoria, drawing from clinic reports of short-term satisfaction but criticized for conflating correlation with causation in low-evidence settings influenced by advocacy over empiricism.^[192] Watchful waiting, conversely, emphasizes comprehensive psychological assessment and monitoring for natural resolution, aligned with desistance data and avoiding iatrogenic persistence from premature affirmation, as early social transition correlates with near-100% continuation rates in some cohorts.^[72] ^[193] This method, historically standard in European clinics, prioritizes addressing co-occurring issues like anxiety or family dynamics before irreversible steps, though affirmative proponents argue it risks short-term harm despite lacking robust comparative trials.^[194]

Participation in Sports

Transgender women who have undergone male puberty retain significant physiological advantages in strength, speed, and power over biological females, even after extended periods of testosterone suppression via hormone therapy. A 2021 review by Hilton and Lundberg analyzed multiple studies and found that transgender women maintain a 9-31% advantage in muscle mass, strength metrics like grip and squat, and hemoglobin levels compared to biological females, with advantages persisting after 2-3 years of therapy. These edges stem from irreversible effects of male puberty, including greater skeletal structure, bone density, and muscle fiber composition, which hormone therapy does not fully mitigate. Empirical data from military and athletic cohorts corroborate this, showing transgender women outperforming cisgender women by 10-50% in key performance indicators post-transition.^[195] A prominent example is swimmer Lia Thomas, who, after competing on the University of Pennsylvania men's team, transitioned and won the NCAA Division I women's 500-yard freestyle championship in March 2022 with a time of 4:33.24, becoming the first openly transgender woman to claim an NCAA title. Thomas's pre-transition rankings were middling among men (e.g., 554th in the 500 free nationally), but post-transition, she achieved top finishes in women's events, including fifth in the 100 free and eighth in the 200 free at the same championships, highlighting retained performance edges. Such cases have fueled debates over competitive equity in sex-segregated sports, where female categories exist to account for average sex-based differences of 10-50% in athletic capabilities. The International Olympic Committee's 2021 Framework on Fairness, Inclusion and Non-Discrimination shifted eligibility from rigid testosterone thresholds (previously <10 nmol/L for 12 months) to sport-specific guidelines emphasizing no presumption of advantage, allowing federations autonomy. Critics, including medical experts, argue this framework fails to safeguard fairness, as it disregards evidence of persistent male advantages and prioritizes inclusion without evidence that suppression eliminates disparities. For instance, a 2024 analysis by Lundberg contended the IOC policy undermines female protections by not requiring proof of equity, potentially eroding decades of progress in women's sports.^[196] By 2025, policy trends have shifted toward sex-based categorization, with the NCAA announcing in February a policy restricting women's sports divisions to athletes assigned female at birth, aligning with sport science on immutable advantages. A U.S. executive order in February 2025 further prohibited transgender women from female sports in federally funded programs, rescinding support for inclusive models deemed unfair. Public opinion reflects this, with a Pew Research Center survey in early 2025 finding 66% of U.S. adults favoring requirements for transgender athletes to compete on birth-sex teams, up from prior years and driven by concerns over female equity. Proponents of inclusion advocate for case-by-case assessments or open categories to balance participation rights, while equity advocates, citing causal links between male biology and performance, prioritize protecting the integrity of female competitions to sustain participation and Title IX gains.^[197]^[198]

Access to Single-Sex Spaces

Access to single-sex spaces, such as bathrooms, prisons, and shelters, has become a focal point of contention between transgender inclusion policies and protections for biological females based on privacy, safety, and sex-based rights. Proponents of self-identification argue that allowing access according to gender identity promotes dignity and reduces discrimination against transgender individuals, while critics, including gender-critical advocates, contend that such policies overlook empirical patterns of male criminality persisting in some transgender women, potentially compromising female safety.^[199]^[200] In correctional systems, policies enabling self-ID have led to documented risks. Canada's Correctional Service implemented an interim policy on December 27, 2017, following Bill C-16, permitting gender-diverse offenders to request housing in facilities matching their self-identified gender, which has resulted in biological males being placed in women's prisons.^[201] This shift correlates with reports of assaults, as evidenced by cases where transgender women with histories of violence against females perpetrated further attacks post-transfer; for instance, in the UK, transgender prisoner Karen White, convicted of rape as a male, sexually assaulted two female inmates in 2017-2018 after placement in a women's facility.^[202] Statistical analyses reinforce these concerns: a Swedish longitudinal study found that transgender women exhibited criminal conviction rates for violent and sexual offenses aligning with biological males rather than females, with 48% of male-to-female trans individuals convicted of any crime compared to 28% of female controls, and elevated risks for violent crimes persisting post-transition.^[199]^[200] Public facilities like bathrooms have seen high-profile incidents highlighting vulnerabilities. At Wi Spa in Los Angeles on July 3, 2021, a biological male identifying as a transgender woman, Darren Merager, entered the women's section, exposed male genitalia, and prompted complaints from female patrons, leading to charges of indecent exposure; Merager, who has a prior history of similar offenses, was banned from the spa but the case underscored policy gaps under California's self-ID framework.^[203]^[204] Gender-critical perspectives emphasize that such events, though not representative of all transgender individuals, reflect male-pattern behaviors in a subset, eroding the rationale for sex-segregated spaces designed to mitigate male-perpetrated harms, which constitute over 90% of sexual violence against women globally.^[199] Women's shelters, intended as refuges from male violence, face analogous challenges with inclusive policies. While comprehensive incident data remains limited, reports from Canadian and U.S. shelters indicate heightened discomfort and safety fears among female residents when biological males are admitted based on self-ID, with some facilities documenting assaults mirroring prison patterns; for example, a 2023 analysis of self-ID in Canadian corrections noted increased vulnerability for female inmates and extended parallels to shelter dynamics.^[205] In response, jurisdictions like the UK have issued guidance clarifying that single-sex spaces can lawfully exclude transgender women to preserve biological sex-based protections, as affirmed in government calls for evidence against erroneous self-ID interpretations in 2024, prioritizing empirical risks over identity claims.^[206] These measures reflect causal realities: physical dimorphism and offense patterns tied to biological sex, not identity, necessitate segregated spaces to safeguard females, a principle upheld despite advocacy for universal access.^[199]

Legal Recognition and Policies

Legal gender recognition policies vary globally, with over 20 countries permitting self-identification without medical or surgical requirements for changing sex markers on official documents. Argentina's Gender Identity Law of 2012 was among the first, allowing adults to alter their name and gender on identity cards and birth certificates via simple declaration before a judge or notary, bypassing hormonal therapy or surgery.^[207] Similar self-ID frameworks exist in Uruguay (2018), Colombia (2015), Ecuador (2016), Spain (2023), and several European nations including Denmark, Norway, and Portugal, often justified as affirming personal autonomy but criticized for potential risks to privacy and fraud prevention in shared spaces.^[208]^[209] In the United States, federal policy under the Trump administration as of January 2025 emphasizes biological sex for Title IX enforcement, rescinding prior expansions that incorporated gender identity and reverting to the 2020 rule defining sex as immutable and binary (male or female at birth).^[210]^[211] This shift prioritizes protections for biological females in education and sports, directing investigations into school policies allowing transgender participation in sex-segregated programs. State-level variations persist, with some requiring clinical diagnoses for ID changes while others align with self-ID.^[212] Anti-discrimination laws prohibit adverse treatment based on gender identity in employment, housing, and services in jurisdictions like Canada, where Bill C-16 (enacted June 2017) amended the Human Rights Act to include gender identity and expression as protected grounds, aiming to curb harassment but sparking debates over compelled speech. Critics, including legal scholars, contend it effectively mandates pronoun usage, as evidenced by Ontario Human Rights Tribunal rulings deeming deliberate misgendering discriminatory in workplaces.^[213]^[214] Empirical studies on employment discrimination yield mixed results: self-reported harassment affects 47% of transgender workers annually, yet field audits find no significant callback disparities post-anti-discrimination laws, suggesting factors like presentation or skills gaps may confound outcomes.^[215]^[216] Transgender poverty rates exceed the general population (approximately 22-29% versus 12-16%), linked not only to reported bias but substantially to elevated comorbidities such as depression, anxiety, and substance use disorders, which impair workforce participation independently of legal protections. Longitudinal data indicate mental health challenges precede transition and persist, contributing to unemployment via reduced productivity rather than discrimination alone, as anti-bias laws show limited causal impact on economic outcomes.^[217]^[218] Balancing rights claims often pits gender identity accommodations against sex-based safeguards, with courts weighing evidence of disparate impacts in areas like prisons and shelters.

Criticisms and Alternative Perspectives

Gender Critical Feminism

Gender critical feminism maintains that biological sex is immutable, binary, and the material basis for women's sex-based oppression under patriarchy, prioritizing protections for female-only spaces, sports, and services over gender identity claims.^[219]^[220] Proponents argue that redefining womanhood around subjective identity erodes these protections, as evidenced by J.K. Rowling's June 10, 2020, essay outlining concerns that trans activism substitutes sex with gender stereotypes, potentially harming vulnerable women and girls by blurring sex-based realities.^[221] A core critique targets ideological inconsistencies in gender identity theory, which rejects sex stereotypes as oppressive yet defines trans women through alignment with feminine norms like dress and mannerisms, implying biology alone insufficiently determines womanhood.^[222] This reliance on stereotypes, gender critical feminists contend, reinforces rather than dismantles patriarchal expectations, contradicting claims of innate, non-stereotypical gender essence.^[223] In the UK, gender critical advocacy contributed to the government's September 2020 decision to abandon self-identification reforms to the Gender Recognition Act, citing risks to single-sex spaces after a consultation revealed widespread concerns over women's safety and rights.^[224] Groups like Sex Matters and Fair Play for Women mobilized evidence-based campaigns highlighting how self-ID could enable male access to female prisons and shelters, preserving sex-based categories amid policy debates.^[225] These efforts underscore opposition to subsuming feminism under trans-inclusive frameworks, viewing such inclusion as diluting sex-specific advocacy central to radical feminist traditions.^[226]

Psychological and Therapeutic Approaches

Prior to the widespread adoption of gender-affirmative models in the 2010s, clinicians at the Dutch gender clinic employed a watchful waiting approach for pre-pubertal children presenting with gender dysphoria, prioritizing observation and treatment of comorbidities over immediate affirmation or intervention.^[227] This strategy aligned with longitudinal data indicating high desistance rates, where the majority of childhood-onset cases resolved naturally by adolescence without persistence into adulthood.^[228] A key study by Steensma et al. (2013) tracked 127 children referred before age 12, revealing that factors such as the intensity of early gender dysphoria and social transition influenced persistence, with approximately 70% desisting post-puberty when comorbidities like anxiety were addressed conservatively rather than affirmed as inherent to gender identity.^[228]^[229] Exploratory psychotherapy emphasizes comprehensive assessment to uncover potential underlying causes of dysphoria, such as trauma, autism spectrum traits, or social influences, often integrating cognitive-behavioral therapy (CBT) to manage high rates of comorbid mental health issues observed in up to 70-90% of cases.^[230] Unlike affirmation-only approaches, which critics argue may reinforce dysphoria iatrogenically by bypassing exploration, CBT targets symptoms like social anxiety or depression that frequently co-occur and can mimic or exacerbate gender-related distress.^[194] For instance, journalist Jesse Singal has highlighted methodological flaws in affirmation studies, noting that short-term improvements may overlook long-term risks, including regret or worsened outcomes from premature identity solidification without addressing root comorbidities. Research on rapid-onset gender dysphoria (ROGD), described by Lisa Littman in a 2018 PLOS One study based on parent reports of 256 cases, suggests social contagion via peer groups and online communities may drive sudden adolescent-onset presentations, potentially amplified by affirmative environments that discourage desistance.^[5] Affirmation's critics, including Littman, posit that it can create a feedback loop of harm by validating transient distress as fixed identity, reducing natural resolution rates observed in watchful waiting cohorts.^[194]^[5] Nordic countries have shifted toward therapy-first models in recent guidelines, reflecting empirical concerns over affirmation's evidence base. Finland's Council for Choices in Health Care (COHERE) in 2020 recommended psychosocial support and psychotherapy as first-line interventions for minors, reserving hormones for exceptional cases after ruling out comorbidities and ensuring dysphoria stability.^[231] Similarly, Sweden's National Board of Health and Welfare (Socialstyrelsen) in 2022 issued guidelines prioritizing exploratory assessment and conservative management, deeming affirmative medicalization unsupported by quality evidence for most youth and restricting it to rigorous research settings due to uncertain benefits and risks like infertility.^[232]^[233] These approaches underscore a return to empirical caution, favoring outcomes data from desistance studies over ideological affirmation.^[234]

Empirical Critiques of Affirmation Model

The Cass Review, an independent evaluation of gender identity services for children and adolescents commissioned by NHS England and published in April 2024, assessed over 100 studies and found the evidence base for gender-affirming medical interventions—such as puberty blockers and cross-sex hormones—to be of low quality, characterized by the absence of randomized controlled trials (RCTs), reliance on non-randomized observational designs, short follow-up durations often under two years, and high risks of bias in outcome reporting.^[235] Systematic reviews within the report rated nearly all evidence as weak, with no high-quality studies demonstrating long-term benefits outweighing risks like bone density loss or fertility impairment.^[9] Long-term outcome studies further underscore methodological limitations, as evidenced by a 2011 Swedish cohort analysis of 324 individuals post-sex reassignment surgery, which reported a 19.1-fold increased suicide mortality risk compared to matched general population controls (adjusted hazard ratio: 19.1; 95% CI 5.8–62.9), persisting up to 30 years post-intervention and indicating no resolution of pre-existing psychiatric vulnerabilities.^[236] Similarly, regret and detransition rates are likely underestimated due to substantial loss to follow-up in affirmation-focused research, with many studies losing 20–60% of participants, potentially masking adverse outcomes as non-responders who discontinue care.^[145]^[237] Prospective follow-up of gender-dysphoric children reveals high desistance rates without affirmative interventions, with clinic-referred boys showing persistence in only 12% of cases by adolescence or adulthood, and aggregated data from multiple studies estimating 60–90% resolution of dysphoria by puberty's end when managed through watchful waiting rather than social or medical transition.^[73] Elevated comorbidities, including autism spectrum disorder (prevalence 15–35% in gender-dysphoric youth versus 1–2% generally) and co-occurring anxiety, depression, or trauma, suggest that gender dysphoria may often stem from or be exacerbated by these untreated conditions, prioritizing their causal investigation over immediate affirmation.^[238]^[239] Such patterns challenge the affirmation model's assumption of persistence, advocating for rigorous differential diagnosis to avoid iatrogenic harm.^[72]

Recent Developments

Policy Changes and Bans

In the United States, 27 states had enacted laws by December 2024 prohibiting puberty blockers, cross-sex hormones, and surgeries for minors experiencing gender dysphoria, with these restrictions upheld or expanded into 2025 amid ongoing legal challenges.^[240] ^[241] State legislatures cited systematic reviews, including the UK's Cass Review, indicating weak evidence for net benefits and risks such as impaired bone development, infertility, and potential regret, prioritizing child protection over immediate affirmation.^[242] The United Kingdom closed the Gender Identity Development Service (GIDS) at Tavistock and Portman on March 31, 2024, after the Cass Review documented inadequate holistic assessments, over-reliance on medicalization, and an evidence base too fragile to support routine puberty blockers for youth.^[243] NHS England suspended routine prescriptions of puberty blockers for those under 18 in March 2024, extending the policy indefinitely in December 2024 following expert recommendations that affirmed the interventions' experimental status and uncertain long-term outcomes.^[242] On January 20, 2025, President Donald Trump signed Executive Order 14168, defining sex federally as an immutable binary classification—male or female—determined biologically at conception, and mandating agencies to cease recognizing gender identity as distinct from sex in policies on healthcare, education, and facilities.^[210] The order directed the cessation of funding for treatments altering biological sex in minors and revoked prior administrations' expansions of gender-based entitlements, framing such measures as essential to counter ideological overreach with empirical biology.^[244] European nations diverged in approach but trended toward caution: Sweden's National Board of Health restricted hormones and blockers for adolescents in 2022, with 2023-2025 policies limiting them to research protocols due to low-quality evidence; Denmark curtailed transitions for under-18s in August 2023, excluding most post-pubertal cases; Finland prioritized therapy over medicalization since 2020, reinforced through 2025; and Germany's 2025 guidelines advised against interventions for youth with transient identifications, emphasizing diagnostics for comorbidities.^[245] ^[246] ^[247] These reforms, informed by national health inquiries paralleling Cass, contrasted with human rights critiques alleging rights violations, though proponents underscored causal evidence of harms outweighing unproven gains in randomized data.^[248]

Declining Identification Rates

Recent surveys indicate a marked decline in self-identification as transgender among Generation Z individuals. Data analyzed by Jean Twenge, a psychology professor at San Diego State University, using the Monitoring the Future dataset, show that among 18- to 22-year-olds, the proportion identifying as transgender fell by nearly 50% between 2022 and 2024, while nonbinary identification dropped by more than 50% in the same period.^[249]^[162] Broader Gen Z trends reflect a peak of 6.8% identifying as transgender or queer in 2022–2023, declining to 3.6% by 2025.^[250]^[251] Similar patterns appear in elite institutions, such as Brown University, where non-male/non-female identifications decreased from 9.2% in 2023 to 3% in 2025, and Phillips Academy Andover, where nonbinary identifications fell from 7.4% in 2023 to 3% in 2025.^[163]^[252] These shifts coincide with increased public scrutiny of transgender visibility following the COVID-19 pandemic, potentially prompting reevaluation of identities adopted during periods of heightened social media influence and isolation.^[253]^[254] Observers attribute the downturn partly to backlash against rapid normalization efforts, including school policies and media portrayals, which may have amplified transient identifications rather than enduring ones.^[162]^[163] The rapid reversal supports hypotheses of social contagion in identity formation, where trends akin to fads rise and fall with cultural momentum, as evidenced by the synchronized peak and subsequent drop across cohorts and institutions.^[249]^[255] This pattern contrasts with stable historical rates of gender dysphoria, suggesting external social dynamics over innate predispositions drove the earlier surge.^[253]^[250]

Scientific Reviews and Debates

The Cass Review, an independent systematic review commissioned by the UK's National Health Service and published in April 2024, evaluated the evidence for gender identity services for children and young people under 18. It concluded that the evidence base for medical interventions such as puberty blockers and cross-sex hormones is of low quality, with few randomized controlled trials and reliance on non-randomized, low-quality studies that often lacked long-term follow-up or control groups. The review highlighted that while some youth experience persistent gender dysphoria, the majority do not progress to medical transition, and psychosocial interventions lack robust evidence of efficacy. It recommended a shift toward holistic, evidence-based care emphasizing mental health assessment over rapid affirmation.^[10]^[256] Similar conclusions emerged from national health authority reviews in Finland and Sweden. Finland's Council for Choices in Health Care in 2020 deemed hormonal treatments for minors experimental, prioritizing psychotherapy for gender dysphoria and restricting blockers and hormones to exceptional cases with rigorous evaluation. Sweden's National Board of Health and Welfare updated guidelines in 2022, advising against routine use of puberty blockers and hormones outside research protocols due to uncertain benefits and risks like infertility and bone density loss, favoring watchful waiting and addressing comorbidities. These assessments, based on systematic evidence appraisals, underscore insufficient high-quality data supporting affirmation as first-line treatment.^[234] Neurobiological and genetic studies remain inconclusive regarding innate biological markers for transgender identity. Meta-analyses and imaging studies from 2023-2025 show some brain volume or connectivity differences in transgender individuals compared to cisgender controls, but these overlap significantly with sex-atypical patterns rather than forming a distinct "transgender brain" category, and findings are inconsistent across studies due to small samples and confounding factors like hormone use. Genetic research has identified no specific variants causally linked to gender dysphoria, with heritability estimates varying widely and environmental influences predominant. Critics argue these studies fail to demonstrate predetermination, as brain plasticity and socialization effects complicate causal inference.^[257]^[258] Research on detransition has expanded since 2023, revealing discontinuation rates of gender-affirming hormones among adolescents ranging from 10-30% within 4 years, often linked to resolution of dysphoria, external pressures, or unmet mental health needs rather than regret alone. Qualitative studies document detransitioners citing rapid affirmation, inadequate screening for comorbidities like autism or trauma, and social contagion as factors, with calls for longitudinal tracking to assess long-term outcomes. This emerging data challenges assumptions of low regret in affirmation models.^[259]^[260] Scientific debates intensify over data interpretation, with affirmation advocates, including organizations like the World Professional Association for Transgender Health (WPATH), defending interventions based on observational satisfaction reports despite methodological flaws, while skeptics emphasize systematic reviews' findings of weak evidence and advocate watchful waiting or exploratory therapy. Proponents of affirmation critique reviews like Cass for alleged bias against low-certainty evidence, whereas detractors highlight overreliance on activist-influenced guidelines amid institutional pressures. These disputes underscore the need for randomized trials, with European shifts reflecting caution against uncritical adoption of affirmation absent causal proof of efficacy.^[261]^[262]

References

[1]
Biological sex is binary, even though there is a rainbow of sex roles
Dec 21, 2022 · Biological sex is defined as a binary variable in every sexually reproducing plant and animal species. With a few exceptions, all sexually ...BIOLOGICAL SEX AS A... · THE VARIOUS... · CONCLUSION: DENYING...
[2]
Considering Sex as a Biological Variable in Basic and Clinical Studies
The classical biological definition of the 2 sexes is that females have ovaries and make larger female gametes (eggs), whereas males have testes and make ...
[3]
Gender Dysphoria: A Review Investigating the Relationship ...
Aug 5, 2020 · Evidence suggests that abnormal biological processes, including mutations in certain genes, can lead to abnormal gonadal development, causing ...
[4]
Gender Dysphoria and Transgender Identity Is Associated with ...
Aug 13, 2020 · They conclude that GD is for the largest part caused by environmental factors, while acknowledging that twin studies have found a modest genetic ...
[5]
Parent reports of adolescents and young adults perceived to show ...
Parents describe that the onset of gender dysphoria seemed to occur in the context of belonging to a peer group where one, multiple, or even all of the friends ...View Reader Comments · Correction · View Figures (14)<|control11|><|separator|>
[6]
[PDF] HOW MANY ADULTS AND YOUTH IDENTIFY AS TRANSGENDER ...
Of the 1.3 million adults who identify as transgender, 38.5% (515,200) are transgender women, 35.9% (480,000) are transgender men, and 25.6% (341,800) reported ...
[7]
Disparities in School Connectedness, Unstable Housing ... - CDC
Oct 10, 2024 · In 2023, 3.3% of U.S. high school students identified as transgender, and 2.2% identified as questioning. Transgender and questioning students ...
[8]
Transgender identity in young people and adults recorded in UK ...
Nov 28, 2023 · The rate of transgender identity recorded in primary care records has increased fivefold from 2000 to 2018 and is highest in the 16-17 and 18-29 age groups.
[9]
Gender medicine 'built on shaky foundations', Cass review finds
Apr 10, 2024 · Analysis finds most research underpinning clinical guidelines, hormone treatments and puberty blockers to be low quality.
[10]
The Final Cass Review and the NHS England Response - SEGM
Apr 11, 2024 · The Cass Report provides a scathing assessment of the gender-affirming approach in general, and the gender-clinic model of care, which ...
[11]
A systematic review on gender dysphoria in adolescents and young ...
Sep 21, 2023 · Results showed that GD adolescents have more suicidal ideation, life-threatening behaviour, self-injurious thoughts or self-harm than their cisgender peers.
[12]
Sex Reassignment Doesn't Work. Here Is the Evidence.
Mar 9, 2018 · The study identified increased mortality and psychiatric hospitalization compared to the matched controls. The mortality was primarily due to ...
[13]
Factors Leading to “Detransition” Among Transgender and Gender ...
Of these, 2242 (13.1%) reported a history of detransition. Of those who had detransitioned, 82.5% reported at least one external driving factor. Frequently ...
[14]
Long-term Outcomes After Gender-Affirming Surgery - PubMed
Oct 1, 2022 · High patient satisfaction, improved dysphoria, and reduced mental health comorbidities persist decades after GAS without any reported patient ...
[15]
Correction of a Key Study: No Evidence of “Gender-Affirming ...
Aug 30, 2020 · Prior studies demonstrated that post-surgery transgender patients suffer from elevated mortality due to cardiovascular disease and suicide (13).
[16]
“Intersex” Does not Violate the Sex Binary - PMC - NIH
May 18, 2023 · If sex is defined by gamete production, sex in human beings is exclusively male and female [Disjunctive syllogism]. Sex is defined by gamete ...
[17]
Evolutionary Biology: The Origins of Two Sexes - ScienceDirect.com
anisogamy — involves genes linked ...
[18]
Sex Is Not a Spectrum - by Colin Wright - Reality's Last Stand
Feb 1, 2021 · Claims that 'sex is a spectrum' rely on fundamental misunderstandings about the nature of biological sex.
[19]
How common is intersex? a response to Anne Fausto-Sterling
Anne Fausto-Sterling s suggestion that the prevalence of intersex might be as high as 1.7% has attracted wide attention in both the scholarly press and the ...
[20]
Sex Redefined: The Idea of 2 Sexes Is Overly Simplistic
Feb 18, 2015 · But they are rare—affecting about 1 in 4,500 people. Some researchers now say that the definition should be widened to include subtle variations ...<|control11|><|separator|>
[21]
The Simple Truth about Biological Sex - Public Square Magazine
Sep 18, 2024 · However, 99.98% of the population are clearly male or female, with XY or XX chromosomes that align with their sex and with anatomy that develops ...
[22]
Why do only two sexes exist for animals? - Biology Stack Exchange
Jun 23, 2012 · To get a non-circular answer to why humans and other mammals have only two sexes, it's helpful to take a look at our evolutionary history.
[23]
How common is intersex? | Leonard Sax MD PhD
Aug 1, 2002 · Fausto-Sterling asserts that 1.7% of human births are intersex. This figure was widely quoted in the aftermath of the book's publication.
[24]
The genetics of sex chromosomes: evolution and implications for ...
Following standard notation, females and males are XX and XY, respectively, in male heterogametic systems, and males and females are ZZ and ZW, respectively, in ...
[25]
SRY: Sex determination - Genes and Disease - NCBI Bookshelf - NIH
SRY, or sex-determining region Y gene, is on the Y chromosome and is important for testis formation. It binds to DNA, altering its properties.Missing: basis peer
[26]
SRY gene: MedlinePlus Genetics
Sep 28, 2022 · The SRY gene provides instructions for making a protein called the sex-determining region Y protein. This protein is involved in male-typical sex development.
[27]
Swyer syndrome: MedlinePlus Genetics
Feb 25, 2022 · SRY gene variants that cause Swyer syndrome prevent production of the sex-determining region Y protein or result in the production of a ...
[28]
Entry - #400044 - 46,XY SEX REVERSAL 1; SRXY1 - OMIM
The designation 'Swyer syndrome' refers to 46,XY complete gonadal dysgenesis. The disorder is caused not only by mutations in the SRY gene but by genes on the ...<|separator|>
[29]
Androgen insensitivity syndrome - Genetics - MedlinePlus
Apr 1, 2024 · As such, affected individuals do not menstruate and are unable to conceive a child (infertile). People with complete androgen insensitivity ...
[30]
Androgen Insensitivity Syndrome - GeneReviews® - NCBI Bookshelf
May 11, 2017 · Androgen insensitivity syndrome (AIS) is typically characterized by evidence of feminization (ie, undermasculinization) of the external genitalia at birth.
[31]
Extensive Literature Review of 46,XX Newborns with Congenital ...
46,XX individuals born with severely masculinized genitals due to congenital adrenal hyperplasia (CAH) who have been assigned male at birth and reared male ...
[32]
Congenital adrenal hyperplasia - Symptoms and causes - Mayo Clinic
Mar 22, 2024 · Congenital adrenal hyperplasia (CAH) is the medical name for a group of genetic conditions that affect the adrenal glands.Missing: masculinization | Show results with:masculinization
[33]
Worldwide cohort study of 46, XY differences/disorders of sex ...
Jun 9, 2024 · The aims of this paper were to review the most common causative genes and rare genes in patients with 46, XY DSDs, analyze global molecular diagnostic cohorts.<|separator|>
[34]
Genomic instability in individuals with sex determination defects and ...
May 23, 2023 · We addressed genomic instability in individuals with Differences of Sex Development (DSD), characterized by gonadal dysgenesis, infertility, high ...
[35]
Substantial but Misunderstood Human Sexual Dimorphism Results ...
Human sexual dimorphism results from sexual selection on males for muscle/strength, and natural selection on females for increased body fat and maternal ...Stature Dimorphism · Body Mass Dimorphism · Dimorphism And Male Mating...<|separator|>
[36]
Sexual Differentiation - Endotext - NCBI Bookshelf - NIH
Jul 24, 2025 · Sex differentiation involves a series of events whereby the sexually indifferent gonads and genitalia progressively acquire male or female characteristics.
[37]
Effects of gendered behavior on testosterone in women and men - NIH
Oct 26, 2015 · Although testosterone exists and functions similarly in women and men, men have markedly higher average testosterone than women. This ...
[38]
Circulating Testosterone as the Hormonal Basis of Sex Differences ...
Following puberty, testosterone production increases (16) but remains <2 nmol/L in women, whereas in men testosterone production increases 20-fold (from 0.3 mg/ ...
[39]
Sex-Related Differences in Gene Expression in Human Skeletal ...
Jan 2, 2008 · There is sexual dimorphism of skeletal muscle, the most obvious feature being the larger muscle mass of men. The molecular basis for this ...
[40]
Sexual dimorphisms in skeletal muscle - PubMed Central - NIH
Many of the observed sex differences have hormonal and molecular mechanistic underpinnings, whereas others have yet to be elucidated.
[41]
Sex Differences in Autoimmune Disease from a Pathological ... - NIH
Autoimmune diseases affect ∼8% of the population, 78% of whom are women. The reason for the high prevalence in women is unclear. Women are known to respond ...Missing: suicide | Show results with:suicide
[42]
Unravelling sex differences in autoimmune diseases - UNSW Sydney
Sep 4, 2024 · Autoimmune diseases are a leading cause of death in women under 65, and they're four times more likely to develop in females than males.Missing: suicide | Show results with:suicide
[43]
Sex differences in human performance - The Physiological Society
Aug 6, 2024 · Males outperform females in many physical capacities because they are faster, stronger and more powerful, particularly after male puberty.
[44]
Sexual dimorphism through androgen signaling - NIH
Jul 27, 2022 · Sexual dimorphisms can be seen in many organisms with some exhibiting subtle differences while some can be very evident.
[45]
Gender Dysphoria Diagnosis - American Psychiatric Association
Criteria: Gender Dysphoria in Adolescents and Adults ... A marked incongruence between one's experienced/expressed gender and assigned gender, of at least six ...Gender Dysphoria Diagnosis · Criteria: Gender Dysphoria... · Disorders Of Sex Development
[46]
[PDF] Gender Dysphoria - American Psychiatric Association
DSM-5 aims to avoid stigma and ensure clinical care for individuals who see and feel themselves to be a different gender than their assigned gender. It replaces ...
[47]
Gender incongruence and transgender health in the ICD
ICD-11 moved gender incongruence to sexual health, replacing outdated terms, and now includes "gender incongruence of adolescence and adulthood" and "gender ...What Is The Icd? · Icd-11 And Gender... · What Is Transgender And What...
[48]
Validity of Categories Related to Gender Identity in ICD-11 and DSM ...
Nov 30, 2021 · ICD-11 gender incongruence (GI), in contrast to DSM-5 gender dysphoria (GD), is explicitly not a mental disorder; neither distress nor ...
[49]
Gender Dysphoria: Practice Essentials, Background, Etiology
May 9, 2022 · According to DSM-5-TR, the prevalence of gender dysphoria is 0.005–0.014% for adult natal males and 0.002-0.003% for adult natal females.Practice Essentials · Background · Etiology · Epidemiology
[50]
Gender Dysphoria in Adults | Counseling Nexus
In adults, prevalence of gender dysphoria ranges from 0.005% to 0.014% for biological men and from 0.002% to 0.003% for biological women (American Psychiatric ...
[51]
Gender Dysphoria - StatPearls - NCBI Bookshelf
Gender dysphoria can be present in congenital adrenal hyperplasia or partial androgen insensitivity syndrome, and DSM 5 recognizes this as a specifier.
[52]
Gender Dysphoria – Prevalence and Co-Morbidities in an ... - Frontiers
Based on the 2011 census reports (9), this indicates a prevalence of GD in 1:14,756 people (0.0067% of the population), categorized into 1:10,154 MTF (0.0098%) ...
[53]
What Went Wrong at the Tavistock Clinic for Trans Teenagers? | SEGM
Jun 17, 2022 · Overall case numbers had risen – from just 72 in 2009-10 to 1,807 in 2016-17 – but there was something more puzzling. Female referrals, once a ...
[54]
Gender identity clinic accused of fast-tracking young adults
Nov 3, 2018 · The parents claim that the huge increase in numbers of children seeking referrals, which has risen from 97 in 2009 to 2,519 in the year to ...
[55]
Gender Discomfort and Autism
Research also suggests that this relationship is bidirectional, where the rate of autism in transgender individuals is between 6 – 26% compared to a 1.85% ...
[56]
Largest study to date confirms overlap between autism and gender ...
About 30,000, or 5 percent, of the cisgender people in the study have autism, the researchers found, whereas 895, or 24 percent, of the gender-diverse people ...
[57]
Autism spectrum disorder and gender dysphoria among adolescents ...
Oct 16, 2025 · The prevalence of GD among those with ASD (0.26%) was greater than the prevalence of GD among those without ASD (0.16%) p < .001. Individuals ...
[58]
Gender Dysphoria – Prevalence and Co-Morbidities in an Irish Adult ...
Prevalence varies based on geographical location, with higher rates in Western Europe and America (0.001–0.002%) (4–6) compared to lower rates in Japan (0.0009 ...
[59]
Prevalence and Comorbidity of Gender Dysphoria in Taiwan, 2010 ...
Jan 24, 2023 · Our review found case numbers and prevalence of GD in 2019 were about twice that of patients in 2010 for both assigned males and assigned females at birth.
[60]
Epidemiology of gender dysphoria and gender incongruence in ...
Jan 24, 2025 · There was a 50-fold increase in recorded prevalence of gender dysphoria/incongruence in children and young people in primary care in England ...
[61]
Gender dysphoria in twins: a register-based population study - Nature
Aug 4, 2022 · estimated heritability at 62%, while Sasaki et al. found a heritability of 41% for adolescent assigned females (aF) and 11% for adult aF, and no ...
[62]
Using twin data to examine heritable and intrauterine hormonal ...
Jul 1, 2025 · To date, heritability estimates for gender identity have come from eight published twin studies. Seven provided evidence suggesting a genetic ...
[63]
Genetic and Environmental Contributions To Gender Diversity
Sep 12, 2025 · This review of the twin literature suggests that there is likely both heritable and non-shared environmental contributions to gender diversity, ...
[64]
2D:4D Suggests a Role of Prenatal Testosterone in Gender Dysphoria
Jan 23, 2020 · Previous studies suggest that high levels of prenatal testosterone (T) in natal females and low levels in natal males might contribute to GD.
[65]
Is exposure to high levels of maternal intrauterine testosterone a ...
We present evidence that male sex, autism, gender dysphoria and non-right-handedness share a common cause, viz. high levels of maternal first-trimester ...Missing: etiology | Show results with:etiology
[66]
A sex difference in the human brain and its relation to transsexuality
Nov 2, 1995 · A female-sized BSTc was found in male-to-female transsexuals. The size of the BSTc was not influenced by sex hormones in adulthood and was ...
[67]
After the trans brain: a critique of the neurobiological accounts of ...
Feb 2, 2024 · This paper critically analyses three main neurobiological hypotheses on trans* identities: the neurobiological theory about the origin of gender dysphoria.
[68]
Issues with the Trans Brain Sex Hypothesis: Part 1 - The BSTc
Sep 14, 2023 · Another critical challenge in utilizing the BSTc as a causal mechanism to explain gender dysphoria lies in its delayed sexual differentiation.
[69]
A 2020 Review of Mental Health Comorbidity in Gender Dysphoric ...
Mar 8, 2021 · Some studies demonstrate that 40-45% of trans adolescents, have some type of psychiatric comorbidity [24]. Among them, the most frequent are ...
[70]
The Gender Dysphoria Diagnosis in Young People Has a “Low ...
Jul 19, 2024 · Adolescent females aged 15–19 had the lowest persistence rate (27.3%), while young males aged 20–24 had the highest persistence rate (49.7%).<|separator|>
[71]
Prevalence and Determinants of Depressive and Anxiety Symptoms ...
Feb 27, 2023 · In conclusion, remarkably high prevalence rates for both probable depression and probable anxiety were identified among transgender people.
[72]
Early Social Gender Transition in Children is Associated with High ...
May 6, 2022 · Of note, the 61%-98% (or the 85%) historic desistance statistic has been critiqued as inflated, by those who noted that some of the children ...
[73]
A Follow-Up Study of Boys With Gender Identity Disorder - PMC
Boys clinic-referred for gender identity concerns in childhood had a high rate of desistance and a high rate of a biphilic/androphilic sexual orientation. The ...
[74]
The Controversial Research on 'Desistance' in Transgender Youth
May 23, 2018 · The researchers found that 80 of the children had desisted by the ages of 15 and 16.
[75]
Gender dysphoria in adolescence: examining the rapid-onset ... - NIH
If it can be said that social contagion processes have been shown to play a role in certain disorders [67–69], and that social media can potentially exacerbate ...
[76]
Study finds no evidence of social contagion among transgender ...
Aug 3, 2022 · Study finds no evidence of social contagion among transgender youths | AAP News | American Academy of Pediatrics.
[77]
A brief history of transgender issues - The Guardian
Jun 2, 2010 · At Hirschfield's infamous clinic, the first sex change operations were performed by Dr Felix Abraham: a mastectomy on a trans man in 1926, a ...
[78]
Ethically Navigating the Evolution of Gender Affirmation Surgery
It was not until 1952 that gender affirmation surgery would become internationally recognized following the well-publicized sex reassignment surgery of World ...Missing: complications | Show results with:complications<|separator|>
[79]
Harry Benjamin and the birth of transgender medicine - PMC - NIH
Dec 11, 2023 · Harry Benjamin (1885–1986) is now best known as the author of the groundbreaking 1966 book The Transsexual Phenomenon and as a pivotal figure in the early ...
[80]
[PDF] The TRANSSEXUAL PHENOMENON Harry Benjamin, MD
... transsexuals, while transsexual desires are not evident (although possibly latent) in most transvestites. It seems to depend upon how deeply and for what.
[81]
The story of the nation's first clinic for gender-affirming surgery | STAT
which, ...
[82]
Benefits of Transsexual Surgery Disputed As Leading Hospital Halts ...
Oct 2, 1979 · Faced with the failure of psychotherapy to change the minds of transsexuals to match their bodies, Johns Hopkins physicians in 1966 began ...<|separator|>
[83]
The Fall of the Nation's First Gender-Affirming Surgery Clinic - PubMed
Oct 4, 2022 · Operating for more than 13 years, the clinic was abruptly closed in 1979. According to the hospital, the decision was made in response to ...
[84]
Standards of Care for the Health of Transgender and Gender ...
Ever since the first World Professional Association for Transgender Health (WPATH) Standards of Care (SOC) was published in 1979 and in subsequent updates ...
[85]
Transgender today - American Psychological Association
Apr 1, 2013 · Treatment issues. In 1980, the American Psychiatric Association added gender identity disorder to the Diagnostic and Statistical Manual (DSM).
[86]
How gender dysphoria and incongruence became medical diagnoses
Jun 1, 2022 · Gender Dysphoria (GD) became a psychiatric diagnosis in the fifth edition of DSM (2013), and Gender Incongruence (GI) appeared in ICD-11, the ...
[87]
How the early internet created a place for trans youth to find one ...
Jun 19, 2021 · In the late 1980s, trans youth started going online to connect with others experiencing gender dysphoria.
[88]
The early internet created a place for trans youth to find one another ...
Jun 22, 2021 · On CompuServe's trans-specific Genderline forum, chatrooms or CDForum, an early trans email list, trans youths were able to ask questions and ...
[89]
From GI Joe to GI Jane: Christine Jorgensen's Story | New Orleans
Jun 30, 2020 · WWII veteran Christine Jorgensen became the first American transgender woman to attain fame for having sex reassignment surgery.
[90]
(Trans)formation: The Story of Christine Jorgensen - PBS
Jun 27, 2023 · On December 1, 1952 Americans were introduced to 26-year-old Christine Jorgensen, one of the first people to successfully undergo gender affirmation surgery.
[91]
Conundrum - New York Review Books
In stock Free delivery over $75May 16, 2006 · The great travel writer Jan Morris was born James Morris. James Morris ... Publication Date: May 16, 2006. Praise. Her woman is shockingly ...
[92]
'The Definition of Possibility Was Inadequate' | Medium
May 30, 2022 · The writer Jan Morris (1926–2020) is most famous for her memoir of her gender transition, Conundrum, published in 1974.
[93]
The rise and fall of gender identity clinics in the 1960s and 1970s
Apr 1, 2021 · Origins of gender affirmation surgery: The history of the first gender identity clinic in the United States at Johns Hopkins. Ann Plast Surg.Missing: complications | Show results with:complications
[94]
The McHugh Factor: The Ideology of Transgenderism Will Brook No ...
May 20, 2020 · In 1979 he oversaw the cessation of transgender surgeries at Johns Hopkins Hospital—which only resumed there in 2017—on grounds that there was ...
[95]
1969: The Stonewall Uprising - LGBTQIA+ Studies: A Resource Guide
June 28, 1969 marks the beginning of the Stonewall Uprising, a series of events between police and LGBTQ+ protesters which stretched over six days.
[96]
Transgender Legal Battles: A Timeline - JSTOR Daily
July 3, 1969 The Stonewall Uprising was just one of the early backlashes to this pattern of inhumane treatment, but this ...
[97]
https://nysba.org/the-unfinished-business-of-lgbtq-equality-five-years-after-obergefell-v-hodges/
[98]
Puberty suppression in adolescents with gender dysphoria
GnRH agonists (GnRHa) are recommended to suppress puberty (3). At the onset of puberty, GnRH pulsatile secretion by hypothalamus begins. Intermittent GnRH ...
[99]
Effectiveness of Puberty Suppression with Gonadotropin-Releasing ...
Conclusions: GnRHa are effective in suppressing the HPG axis in transgender youth, similar to that observed in children with CPP. Keywords: puberty suppression, ...
[100]
Pubertal Suppression in Transgender Youth - ScienceDirect.com
GnRHas are the treatment of choice for pubertal suppression in the gender dysphoric patient and are recommended to be started at Tanner stage 2.
[101]
[PDF] The Truth About 'Puberty Blockers' - Congress.gov
Aug 4, 2023 · But it has never approved them for gender dysphoria, the clinical term for the belief that one's body is the wrong sex. Thus the drugs, led by ...
[102]
The Dutch Studies and The Myth of Reliable Research in Pediatric ...
Jan 11, 2023 · The Dutch researchers began to medically transition gender dysphoric adolescents in the late 1980s and early 1990s—just as medicine was starting ...
[103]
The Dutch Protocol for Juvenile Transsexuals: Origins and Evidence
Sep 19, 2022 · It has been a quarter of a century since Dutch clinicians proposed puberty suppression as an intervention for “juvenile transsexuals,” which became the ...
[104]
Re-evaluation of the Dutch approach: are recently referred ... - NIH
Aug 31, 2019 · Puberty suppression was first introduced as a part of affirming treatment at the Center of Expertise on Gender Dysphoria in Amsterdam in The ...
[105]
Short-term outcomes of pubertal suppression in a selected cohort of ...
In GD, GnRHa can be used from the early/middle stages of puberty with the aim of delaying irreversible and unwanted pubertal body changes and giving young ...
[106]
Puberty blockers for gender dysphoric youth: A lack of sound science
Sep 15, 2022 · GnRH-analogs have been used for decades to successfully delay the early onset of puberty in children with precocious puberty.
[107]
Short-term outcomes of pubertal suppression in a selected cohort of ...
There was no change from baseline in spine BMD at 12 months nor in hip BMD at 24 and 36 months, but at 24 months lumbar spine BMC and BMD were higher than at ...
[108]
Gender dysphoria in children: puberty blockers study draws further ...
Sep 20, 2019 · Close examination of existing studies indicates that use of puberty blockers in transgender young people commonly results in loss of bone mineral density.Missing: short- | Show results with:short-
[109]
Puberty suppression in adolescents with gender dysphoria - Frontiers
Jun 13, 2024 · There is concern that puberty blockers may delay normal bone development and affect peak bone mass (Table 4) by inhibiting normal endogenous ...
[110]
Impact of gender-affirming treatment on bone health in transgender ...
Results consistently indicate a negative impact of long-term puberty suppression on bone mineral density, especially at the lumbar spine.
[111]
Overview of masculinizing hormone therapy
Jun 17, 2016 · Sexual and gonadal effects include an increase in libido, clitoral growth, vaginal dryness, and cessation of menses. An ovulatory state is ...
[112]
Hormone therapy for transgender patients - PMC - NIH
Cross-sex hormone therapy has been shown to have positive physical and psychological effects on the transitioning individual and is considered a mainstay ...
[113]
Information on Testosterone Hormone Therapy
One known risk is that testosterone can make your blood become too thick, otherwise known as a high hematocrit count, which can cause a stroke, heart attack or ...
[114]
A Review of Treatment Regimens, Outcomes, and Adverse Effects
This review will discuss the endocrinological treatment of male-to-female (M→F) and female-to-male (F→M) transsexual people.
[115]
Urological and Gynaecological Considerations for the Use of ...
Nov 2, 2022 · Tanner stage 2 generally occurs at approxi- mately 10–11 yr of age for AFAB individuals and 11–12 yr of age for AMAB individuals, but with ...<|control11|><|separator|>
[116]
Fertility concerns of the transgender patient - PMC - PubMed Central
Transmen can choose to undergo cryopreservation of oocytes or embryos, which requires hormonal stimulation for egg retrieval. Uterus preservation allows ...
[117]
Desire for children and fertility preservation in transgender and ...
Semen preservation before gender affirming hormone treatment is strongly recommended. •. TGD people's journey to parenthood is related to their mental ...
[118]
Adverse effects of gender‐affirming hormonal therapy in ... - NIH
Besides, transgender persons taking gender‐affirming HT may have an increased risk for depression, cardiovascular disease, dyslipidemia, and decreased bone ...3. Results · 3.1. Transgender Men · 3.2. Transgender Women
[119]
Thromboembolic risk with gender-affirming hormone therapy
In these cohorts, estrogen dose positively correlated with thromboembolic risk. Trans women may be administered 2-to-15 times the dose that cis women receive ...
[120]
Thrombotic risk associated with gender-affirming hormone therapy
TG women using estrogen appear to be at increased risk of both arterial and venous thrombosis, which may increase with longer time on estrogen.
[121]
Hopkins Hospital: a history of sex reassignment
May 1, 2014 · But in 1979, Hopkins stopped performing the surgeries and never resumed. In the 1960s, the idea to attempt the procedures came primarily from ...
[122]
Gender-Affirming Mastectomy Trends and Surgical Outcomes in ...
Complications included hematoma (3.6%), wound infection (2.9%), hypertrophic scars requiring steroid injection (2.9%), seroma (0.7%), and suture granuloma (0.7 ...
[123]
Female-to-Male Chest Surgery in Transgender Patients - NIH
The most common postoperative complication following mastectomy is hematoma. ... In our study, the hematoma rate was 4.9%, which is in line with the literature.Missing: peer | Show results with:peer
[124]
Complications Following Gender-Affirming Phalloplasty: A NSQIP ...
Mar 26, 2024 · Abstract. Background Gender-affirming phalloplasty has a complication rate as high as 76.5%. This is the first study to determine the ...
[125]
Complications and Patient-reported Outcomes in Transfemale ...
Mar 19, 2021 · Complications for intestinal vaginoplasty were as follows: 2% (<0.1%–9%, I2 = 83.3%) of fistula, 14% (5%–26%, I2 = 91.7%) of stenosis and ...Missing: phalloplasty | Show results with:phalloplasty
[126]
Operative Management of Complications Following Intestinal ...
There were 215 complications reported across 654 vaginoplasties (33% overall complication rate). Average return to operating room rate was 18%. The most common ...Missing: bottom | Show results with:bottom<|separator|>
[127]
WPATH SOC-8: Changes to gender-affirming surgery in B.C.
As part of the new standards, only one surgical care planning letter of recommendation, is needed for all genital surgeries (previously, two letters of ...
[128]
[PDF] WPATH and WA Standards for Gender Affirming Surgery
Criteria for Breast/Chest, Facial, Vocal Surgery : 1. Persistent, well-documented gender dysphoria;. 2. Capacity to make a fully informed decision and to ...
[129]
Gender Reassignment Surgery Cost Guide | Price Breakdown
Oct 9, 2024 · Understanding the Cost of Gender Reassignment Surgery ; Procedure Costs, Price Range* ; Chest reconstruction top surgery, $8,500 – $11,500.Missing: 2023-2025 | Show results with:2023-2025
[130]
Does Medicare cover gender reassignment surgery?
For example, according to one 2022 study, an orchiectomy costs around $6,927, a vaginoplasty costs $45,080, and a phalloplasty costs $63,432. How much a person ...Missing: uninsured | Show results with:uninsured
[131]
How To Afford Transgender Surgery Expenses – Forbes Advisor
Aug 19, 2025 · Bottom surgeries, such as vaginoplasty or phalloplasty, can cost $25,600 and $24,900, respectively, according to estimates from The Philadelphia ...
[132]
Hormone Therapy, Mental Health, and Quality of Life Among ...
Hormone therapy was associated with increased QOL, decreased depression, and decreased anxiety. Associations were similar across gender identity and age.Missing: regimens physiological
[133]
A systematic review of psychosocial functioning changes after ...
May 22, 2023 · Gender-affirming hormone therapy was consistently found to reduce depressive symptoms and psychological distress.Missing: regimens | Show results with:regimens
[134]
Association Between Gender-Affirming Surgeries and Mental Health ...
Apr 28, 2021 · In this study, we demonstrate that undergoing gender-affirming surgery is associated with decreased odds of past-month severe psychological ...
[135]
Long-Term Follow-Up of Transsexual Persons Undergoing Sex ...
Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity than the ...
[136]
Analysis of Mortality Among Transgender and Gender Diverse ...
Jan 30, 2023 · In this cohort study of 139 484 individuals, TGD people had elevated overall mortality compared with cisgender people, specifically deaths from external causes.
[137]
Psychiatric Diagnoses and Comorbidities in a Diverse, Multicity ...
Of the 298 transgender women, 41.5%of participants had 1 or more mental health or substance dependence diagnoses; 1 in 5 (20.1%) had 2 or more comorbid ...
[138]
Levels of depression in transgender people and its predictors
Aug 1, 2018 · This study confirms that non-treated transgender individuals have an increased risk of a depressive disorder.
[139]
Mental health in transgender individuals: a systematic review
Of the reviewed articles, 72 examined the prevalence of mood and anxiety disorders; 8 examined eating disorders; 43 examined the prevalence of suicidal or self- ...
[140]
What does the scholarly research say about the effect of gender ...
Among the positive outcomes of gender transition and related medical treatments for transgender individuals are improved quality of life, greater relationship ...
[141]
Long-Term Regret and Satisfaction With Decision Following Gender ...
Oct 1, 2023 · The regret rate following gender-affirming surgery is thought to be approximately 1%; however, previous studies relied heavily on ad hoc instruments.
[142]
A systematic review of patient regret after surgery
Regret after gender affirming surgery is less than 1 %. Regret after elective plastic surgery operations is significantly higher.
[143]
Detransition needs further understanding, not controversy | The BMJ
Jun 14, 2023 · Those who disconnect from care or who refuse to participate in gender care follow-up studies, over 30% in some studies,20 are poorly understood ...Missing: empirical | Show results with:empirical
[144]
Detransition Among Transgender and Gender-Diverse People—An ...
This study found that the 4-year gender-affirming hormone continuation rate was 70.2% with 81% for the transfeminine group and 64% for the transmasculine group.Missing: empirical | Show results with:empirical
[145]
Accurate transition regret and detransition rates are unknown - SEGM
Sep 11, 2023 · At least one study showed that fewer than one quarter of detransitioners returned to their clinicians to tell them about their decision to ...
[146]
Discontinuing hormonal gender reassignment: a nationwide register ...
Aug 19, 2024 · This study aimed to assess the proportion of patients who discontinued their established hormonal gender transition and the risk factors for discontinuation.
[147]
Keira Bell: My Story
Apr 7, 2021 · As a teen, she transitioned to male but came to regret it. Here's how it felt to enter history in the trans debate.
[148]
How Common is Detransition? A Review of all the Evidence - Medium
Mar 24, 2023 · Pooling all high-reliability studies, the combined regret/detransition rate was 2.5–2.7% (n=203 of 7,500–8,250). Potential sources of positive ...
[149]
Bone health in transgender people: a narrative review - PMC - NIH
May 27, 2022 · The maintenance or increase in BMD shown in short-term longitudinal studies emphasizes that GAHT does not have a negative effect on BMD in adult ...
[150]
Longer treatment with puberty-delaying medication in transgender ...
Jun 12, 2022 · A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new ...Missing: short- | Show results with:short-
[151]
Cross-sex Hormones and Acute Cardiovascular Events in ... - NIH
In summary, the present study demonstrated that cross-sex estrogen is a risk factor for VTE and probably ischemic stroke among transfeminine persons. We also ...
[152]
Impact of Gender-Affirming Hormonal Therapy on Cardiovascular ...
Sep 10, 2024 · GAHT can adversely affect lipid profiles, potentially increasing the risk of myocardial infarction and ischemic stroke. This risk is attributed ...
[153]
Fertility Details for Trans Women - FertilityIQ
Estrogen in particular has harmful effects on sperm production. In many cases those effects can cause permanent damage, impeding the ability to ever produce ...<|separator|>
[154]
Puberty blockers could cause long-term fertility issues in boys, study ...
Apr 11, 2024 · Puberty blockers could cause long-term fertility and health issues for boys, study finds: 'May be permanent'. Mayo Clinic researchers identified ...
[155]
Prostate cancer in transgender women: considerations for screening ...
For patients who have had a vaginoplasty, an MRI scan will characterise the volume and length of the neovagina as well as assess the presence of a bowel graft ...
[156]
Long-Term Follow-Up of Transsexual Persons Undergoing Sex ...
Feb 22, 2011 · This study found substantially higher rates of overall mortality, death from cardiovascular disease and suicide, suicide attempts, and ...
[157]
Neovaginal squamous cell carcinoma in a transgender woman - NIH
Jan 27, 2025 · This report presents a rare case of squamous cell carcinoma of the neovagina in a transgender woman and offers insights into treatment, particularly concerning ...
[158]
Understanding transgender people, gender identity and gender ...
Mar 9, 2023 · Gender identity refers to a person's internal sense of being male, female or something else; gender expression refers to the way a person ...
[159]
Gender identity - APA Dictionary of Psychology
Nov 15, 2023 · Many people describe gender identity as a deeply felt, inherent sense of being a boy, a man, or male; a girl, a woman, or female; or a nonbinary ...
[160]
Sexual orientation and gender identity: review of concepts ... - NIH
Sep 18, 2015 · The concept of gender identity evolved over time to include those people who do not identify either as female or male: a “person's self concept ...
[161]
[PDF] How Many Adults and Youth Identify as Transgender in the United ...
Over 2.8 million adults (aged 18 and older) and youth (aged 13 to 17) identify as transgender in the United States, or 1.0% of those aged 13 and older.Missing: binary | Show results with:binary
[162]
https://www.persuasion.community/p/transgender-identity-really-has-fallen
[163]
Why Are Fewer Young People Identifying as Trans?
Oct 14, 2025 · In 2023, 9.2% identified as neither male nor female. This year, that number has crashed to just 3%. A similar story emerges at Brown University ...Missing: prevalence | Show results with:prevalence
[164]
CMV: Being Non-Binary reinforces the idea of gender roles. - Reddit
Apr 17, 2020 · I believe that changing your gender identity just reinforces the idea that these things are traditionally female (or male).Missing: criticism | Show results with:criticism
[165]
Gender Trouble Summary and Study Guide | SuperSummary
Butler's primary aims in the work are to make a case for rejecting an essential female identity as the basis for feminist practice and to come up with an ...
[166]
Judith Butler: Gender and Performativity - ReviseSociology
Feb 24, 2025 · Judith Butler argues that gender is a performative act shaped by cultural norms rather than a fixed identity. She contends that historical ...
[167]
Trans Books by Trans Authors (581 books) - Goodreads
Trans Books By Trans Authors ; 1. Nevada ; 2. Stone Butch Blues ; 3. If I Was Your Girl ; 4. Whipping Girl: A Transsexual Woman on Sexism and the Scapegoating of ...
[168]
[PDF] Transgender Representation in the Media - Encompass
Nearly all samples utilized negative stereotypes of transgender people. Many samples focused on transgender characters in a joking nature, making light of ...
[169]
Transgender Musicians Who Made History - Google Arts & Culture
From pop to punk, here's five artists to know · 1. Jayne County · 2. Wendy Carlos · 3. Shea Diamond · 4. Kim Petras · 5. Laura Jane Grace.
[170]
Why aren't there any famous transgender musicians outside of pop ...
Jun 16, 2025 · Anway, back in 2023 German artist Kim Petras became the first trans singer to win a Grammy for the song “Unholy”. She is very well known to many ...
[171]
Victims or Villains: Examining Ten Years of Transgender Images on ...
Transgender characters were cast in a "victim" role at least 40% of the time. Transgender characters were cast as killers or villains in at least 21% of the ...
[172]
A Look at the History of Trans Representation in Media with Zoey Luna
In early portrayals, transgender characters more commonly faced stereotypical storylines, such as in Glen or Glenda (1954) & Myra Breckenridge (1970). How do ...
[173]
'Third-class citizens': trans actors see stereotyping and exclusion in ...
Jul 9, 2018 · Actors say industry hires men to play trans women, and vice versa, while promoting misconceptions about trans identity.
[174]
Where We Are on TV Report 2023-2024 - GLAAD
GLAAD's annual Where We Are On TV report not only propels national conversations about LGBTQ representation, but informs GLAAD's own advocacy within the ...Summary of Broadcast Findings · Representation of... · Gender Representation
[175]
There Were Only Two Trans Characters Across All of 2023's Major ...
Sep 17, 2024 · Transgender representation in major studio films dropped sharply in 2023 after reaching a record high in 2022, according to a new report from the LGBTQ+ media ...
[176]
Media portrayals of transgender people - Wikipedia
Research has found that viewing multiple transgender TV characters and stories improves viewers' attitudes toward transgender people and related policies.
[177]
“Emilia Pérez” is Not Good Trans Representation - GLAAD
Nov 15, 2024 · These critics understand how inauthentic portrayals of trans people are offensive and even dangerous. If these reviews make you want to learn ...
[178]
Negative Transgender-Related Media Messages Are Associated ...
Overall, 97.6% reported seeing negative depictions of transgender people in the media in the past 12 months, mostly in print media (93.9%), on TV (93.8%), and ...
[179]
Social transition in young trans people accessing gender-affirming ...
Jun 20, 2025 · The vast majority expressed preferences to socially transition by changing their presentation (96.0%), name (89.6%), and/or pronouns (94.3%).Missing: rates | Show results with:rates
[180]
Father Challenges New Jersey School's Secret “Social Transition” of ...
Aug 4, 2025 · In many cases, no parental consent is necessary, and some policies even require that school officials hide these so-called “social transitions” ...
[181]
[PDF] MODEL SCHOOL DISTRICT POLICY ON TRANSGENDER AND ...
Students ready to socially transition may initiate a process to change their name, pronoun, attire, and access to gender-related programs, activities, and.
[182]
18 years of experience of the Gender Identity Unit of Catalonia
After a median follow-up time of 2.6 years, a consistently high rate (97.6%) of persistence of transgender identity in minors was observed. Extending previous ...Original Article · Materials And Methods · Discussion
[183]
Do children grow out of gender dysphoria? - Transgender Trend
On average 80% of children change their minds and do not continue into adulthood as transgender. Some of these studies are very old, the first being published ...
[184]
[PDF] Pronouns and Suicide Prevention - Minnesota Department of Health
Jun 2, 2022 · Transgender and nonbinary youth who reported having pronouns respected by all the people they lived with attempted suicide at half the rate of ...<|separator|>
[185]
[PDF] Pronouns Usage Among LGBTQ Youth - The Trevor Project
Affirming LGBTQ youth's gender by using pronouns that align with their gender identity has been shown to improve mental health outcomes. Specifically, The ...
[186]
Misgendering: Exploring the Harmful Impact of It - Talkspace
Sep 8, 2023 · By contrast, research also shows that reaffirming gender-preferred pronouns and names can have a significantly positive and profound impact.
[187]
Misgendering and the health and wellbeing of nonbinary people in ...
Nov 10, 2023 · The impact of these experiences can lead to depression, hypervigilance, impaired social functioning, suicidality, and disordered eating (Barr et ...Missing: preferred | Show results with:preferred
[188]
Problems with Preferred Pronouns - Stand to Reason
Jun 6, 2023 · They believe it's a simple act of kindness that engenders relationship and avoids unnecessary distress in a transgender person's mental health.
[189]
https://www.researchgate.net/publication/325443416_The_myth_of_persistence_Response_to_A_critical_commentary_on_follow-up_studies_and_%27desistance%27_theories_about_transgender_and_gender_non-conforming_children_by_Temple_Newhook_et_al_2018
[190]
The myth of persistence: Response to “A critical commentary on ...
Aug 7, 2025 · Furthermore, evidence suggesting a significant rate of desistance among children 1 with gender dysphoria complicates the ethical landscape.
[191]
Cass Review: Gender care report author attacks 'misinformation' - BBC
Apr 20, 2024 · Dr Hilary Cass says adults who deliberately spread false information are putting young people at risk.Missing: key | Show results with:key
[192]
Puberty blockers for gender dysphoria in youth: A systematic review ...
Within a range of 12–36 months, 92% of individuals who received puberty blockers progressed to receiving gender affirming hormone therapy (proportion 0.92 (95% ...
[193]
Ensuring Comprehensive Care and Support for Transgender and ...
Watchful waiting is based on binary notions of gender in which gender diversity and fluidity is pathologized; in watchful waiting, it is also assumed that ...
[194]
Exploring Desistance in Transgender and Gender Expansive Youth ...
Desistance is a concept that has been poorly defined in the literature, yet greatly impacts the arguments for and against providing gender-affirming care.
[195]
Iatrogenic Gender Dysphoria and Harm Cycle in Gender Affirming ...
Mar 27, 2025 · Gender social transition of prepubertal children will increase dramatically the rate of gender dysphoria persistence when compared to follow ...
[196]
Transgender Women in the Female Category of Sport
Dec 8, 2020 · Despite this modest reduction in strength, transgender women retained a 17% grip strength advantage over transgender men measured at baseline.
[197]
Medical experts criticise new IOC framework on participation of ...
Jan 18, 2022 · A group of medical experts have criticised the International Olympic Committee's (IOC) framework for transgender and differences in sex ...Missing: critiques | Show results with:critiques
[198]
NCAA announces transgender student-athlete participation policy ...
Feb 6, 2025 · The new policy limits competition in women's sports to student-athletes assigned female at birth only.
[199]
On policies restricting trans people, Americans have become more ...
Feb 26, 2025 · Two-thirds of U.S. adults favor laws and policies that require trans athletes to compete on teams that match their sex assigned at birth.
[200]
Transgender women criminality shows male pattern
Dec 12, 2020 · Transgender women in prison exhibit a male-type pattern of criminality, new data confirms. Crimes match birth sex not gender identity. So.
[201]
[PDF] Evidence and Data on Trans Women's Offending Rates
It compared the likelihood of a person having one or more criminal convictions, and convictions for violent crime (defined as “homicide and attempted homicide, ...
[202]
[PDF] Examination of Gender Diverse Offenders - à www.publications.gc.ca
In accordance with Bill C-16, on December 27, 2017, the Correctional Service of Canada (CSC) implemented its interim policy for gender diverse offenders to ...
[203]
Sexual assaults in women's prison reignite debate over transgender ...
Sep 9, 2018 · A leading prison reformer has said prisoners who have committed violent offences against women should not be able to transfer to women's prisons.
[204]
Wi Spa: Person at center of transgender protests facing indecent ...
A person who identifies as a transgender female at the center of an incident at a Los Angeles spa has been charged with indecent exposure.
[205]
Exclusive: WiSpa Suspect Not Guilty on All Nine Counts of Indecent ...
Jun 1, 2025 · It instructed 'managers on duty' not to admit customer Darren Merager, the now 55-year-old heterosexual male who also identifies as transgender ...
[206]
How gender self-identification policy places women at risk in prison
Feb 6, 2023 · Evidence is emerging that in Canada, the CD100 policy change actively places women at risk, actively undermines their rights, and actively ...Missing: bathrooms | Show results with:bathrooms
[207]
Call for input: Incorrect guidance on single-sex spaces and gender ...
May 1, 2024 · The government seeks examples of incorrect guidance that suggests people have a legal right to access single-sex spaces based on self- ...Missing: 2023 | Show results with:2023
[208]
[PDF] English Translation of Argentina's Gender Identity Law as approved ...
Whenever requested by the individual, the adopted first name must be used for summoning, recording, filing, calling and any other procedure or service in public ...
[209]
A look at the 15+ countries which now allow gender self-ID - Canary
Jan 11, 2023 · Several South American countries have since adopted similar laws, including Uruguay, Colombia, Bolivia, Ecuador, and Peru.
[210]
Legal gender recognition - Rainbow Map - ILGA-Europe
Legal gender recognition is based on self-determination in Belgium, Denmark, Finland, Germany, Iceland, Ireland, Luxembourg, Malta, Norway, Portugal, Spain and ...
[211]
Defending Women From Gender Ideology Extremism And Restoring ...
Jan 20, 2025 · It is the policy of the United States to recognize two sexes, male and female. These sexes are not changeable and are grounded in fundamental ...
[212]
U.S. Department of Education to Enforce 2020 Title IX Rule ...
Jan 31, 2025 · The department will return to enforcing Title IX protections on the basis of biological sex in schools and on campuses. Returning to the 2020 ...
[213]
Trump Administration Sharpens Focus on Title IX: Joint DOJ-ED ...
May 1, 2025 · Read more about how Trump's new Title IX investigations team targets gender identity policies in schools, and what it means for compliance ...
[214]
An Act to amend the Canadian Human Rights Act and the Criminal ...
Jun 19, 2017 · This enactment amends the Canadian Human Rights Act to add gender identity and gender expression to the list of prohibited grounds of discrimination.
[215]
[PDF] Forced speech in C-16 - Senate of Canada
Bill C-16 may require people to use non-gendered speech against their will. (The Ontario Human Rights Commission agrees.) (a) C-16 threatens to compel speech.
[216]
More than 80% of transgender employees in the US have ...
Nov 19, 2024 · Forty-seven percent of transgender employees reported workplace discrimination or harassment in the past year compared to 15% of cisgender LGBQ ...Missing: studies empirical
[217]
What's in a name? Evidence of transgender labor discrimination in ...
The study concludes that there is no significant correlation between the enactment of antidiscrimination laws and transgender discrimination, despite finding a ...
[218]
[PDF] LGBT POVERTY IN THE UNITED STATES A study of differences ...
Poverty rates differ by sexual orientation and gender identity. LGBT people are more likely to experience poverty after accounting for other factors.
[219]
Increased vulnerability to psychological distress and suicidal ...
Potentially as a result of these intersecting factors, transgender people have disproportionately higher rates of poor mental health compared to cisgender ...
[220]
Holly Lawford-Smith: What is Gender-Critical Feminism? (And why is ...
Gender critical feminism is not 'about' trans. It is about sex. But because it is about sex, it clashes with gender identity ideology, which is at the heart of ...
[221]
On gender, sex and a generous feminist politics in anxious times
Apr 16, 2020 · Gender critical feminism views sex as immutable and the basis for women's oppression, focusing on women as a class subject to male domination.
[222]
J.K. Rowling Writes about Her Reasons for Speaking out on Sex and ...
Jun 10, 2020 · I've got five reasons for being worried about the new trans activism, and deciding I need to speak up.
[223]
Transgender Ideology Is Riddled With Contradictions. Here Are the ...
Feb 9, 2018 · D., researches and writes about marriage, bioethics, religious liberty, and political philosophy. Now, activists claim that gender identity is ...
[224]
The Contradiction at the Heart of Gender Debates - Skeptic Magazine
Aug 18, 2025 · Gender identity has become one of the most pressing–and polarizing–topics in today's cultural landscape. Major medical associations have ...
[225]
Gender Recognition Act reform: consultation and outcome
Feb 18, 2022 · Following consultation, the UK Government has decided not to introduce a non-assessment/self-identification process for legal gender recognition ...Missing: blocked | Show results with:blocked
[226]
Confronting complex alliances: Situating Britain's gender critical ...
May 23, 2024 · However the reforms were abandoned in England and Wales in 2020. In Scotland, reforms were passed but then constitutionally blocked by the UK ...
[227]
Fundamentally misunderstanding gender critical feminism | by
May 8, 2019 · For gender critical or radical feminists our “central tenet is that women as a biological class are globally oppressed by men as a biological ...
[228]
Gender-Affirming Care for Trans Youth Is Neither New ... - Julia Serano
May 16, 2023 · While the Dutch group was not in favor of any interventions for pre-pubescent gender-dysphoric children (they called this “watchful waiting”; ...
[229]
Factors associated with desistence and persistence of childhood ...
Objective: To examine the factors associated with the persistence of childhood gender dysphoria (GD), and to assess the feelings of GD, body image, and sexual ...
[230]
[PDF] Desisting and persisting gender dysphoria after childhood
Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. T. SteensmaJenifer K. McGuireB. Kreukels ...
[231]
the need for thorough assessment and treatment of gender ... - NIH
'Cantor says “Although almost all clinics and professional associations in the world use what's called the 'watchful waiting approach' to helping gender diverse ...Missing: outcomes | Show results with:outcomes
[232]
Medical gender reassignment in minors – why are we cautious in ...
National guidelines for the medical treatment of gender dysphoria (GD) associated with variations in gender identity among minors were issued in June 2020, ...
[233]
Care of children and adolescents with gender dysphoria
Care of children and adolescents with gender dysphoria – Summary of national guidelines – December 2022 - Socialstyrelsen.
[234]
Summary of Key Recommendations from the Swedish National ...
Feb 27, 2022 · Three of the recommendations provide guidance for social support for gender dysphoric youth and their families; nine focus on the assessment of ...
[235]
Swedish Transgender Treatment Guidelines for Youth - SEGM
Sep 24, 2024 · A recent submission of an English translation of Sweden's official 2022 national practice guideline for children and adolescents with gender dysphoria.
[236]
Full article: The Cass Review; Distinguishing Fact from Fiction
Jun 6, 2025 · The correct approach to the care of children and young people who are questioning their gender or experiencing gender dysphoria is one of ...
[237]
Long-term follow-up of transsexual persons undergoing sex ...
Feb 22, 2011 · Conclusions: Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and ...
[238]
The Detransition Rate Is Unknown | Archives of Sexual Behavior
Jun 12, 2023 · Loss to follow-up, premature outcome measurement, flawed instruments, and irrelevant samples all contribute to produce unreliable regret, ...
[239]
Autism Spectrum Disorder and Gender Dysphoria/Incongruence. A ...
May 20, 2022 · Interestingly, among adolescents diagnosed with GID, 6.5% received a co-occurring diagnosis of ASD, whereas 1.9% of children with GID were ...
[240]
Mental Health of Youth With Autism Spectrum Disorder and Gender ...
Nov 1, 2023 · The purpose of this study was to examine associations between ASD, GD, and MH diagnoses (anxiety, depression, eating disorder, suicidality, and self-harm)
[241]
States that have passed laws restricting gender-affirming care ... - CNN
Dec 4, 2024 · Twenty-seven states have passed bans on gender-affirming health care for transgender children and teenagers, according to a CNN analysis.
[242]
States With Bans on Gender-Affirming Care for Minors
Dec 4, 2024 · Transgender minors and their parents, guardians and doctors have challenged bans in 18 states, with mixed results.<|separator|>
[243]
Ban on puberty blockers to be made indefinite on experts' advice
Dec 11, 2024 · The NHS stopped the routine prescription of puberty blocker treatments to under 18s in March 2024, following the Cass Review into gender ...
[244]
NHS England Stops Prescribing Puberty Blockers and Updates its ...
Mar 29, 2024 · GIDS at the Tavistock will close its doors on March 31, 2024. The initial plan to shut down GIDS at the Tavistock in 2023 was delayed, but ...
[245]
HHS Takes Action on President Trump's Executive Orders ...
Feb 19, 2025 · HHS took action to support President Trump's executive orders defending women and children and restoring the concept of biological truth in federal government.
[246]
Youth Gender Medications Limited in England, Part of Big Shift in ...
Apr 9, 2024 · Five European countries have recently restricted hormone treatments for adolescents with gender distress. They have not banned the care, unlike ...
[247]
Denmark Joins the List of Countries That Have Sharply Restricted ...
Aug 17, 2023 · In Finland and Sweden, youth with post-puberal onset of gender dysphoria are not typically considered to be candidates for medical transition in ...
[248]
2025 German Guidelines for Diagnosis and Treatment of Gender ...
Mar 26, 2025 · Youth with temporary transgender identification should not undergo medical transition. The Guidelines emphasize that youth with temporary ...<|separator|>
[249]
The UK is the latest country to ban puberty blockers for trans kids ...
Dec 13, 2024 · A handful of European countries – such as Sweden, Denmark, and France – have also moved to limit their use to research settings or in ...
[250]
https://www.thecentersquare.com/national/article_2a1d90be-8b34-483a-902c-9097b1e26174.html
[251]
Report: Sharp decline in trans-identifying youth between 2023 and ...
Oct 16, 2025 · (The Center Square) – A sharp decline in Gen Z Americans identifying as transgender and queer has occurred, from 6.8% identifying as a ...
[252]
Considerable Decline in Trans and Queer Identification in Gen Z
Oct 16, 2025 · The number decreased from 6.8% in 2022 and 2023 to 3.6% in the most recent survey. In many elite colleges, numbers have declined, including at ...<|control11|><|separator|>
[253]
Students identifying as nonbinary on the decline, new study reveals
a steady decline compared to 5.2% ...
[254]
Why are fewer young people identifying as trans? - UnHerd
Oct 14, 2025 · By comparison, the figure was 5.2% in 2024 and 6.8% in both 2022 and 2023. In other words, the share of trans-identified students has ...Missing: Diego State<|separator|>
[255]
https://www.generationtechblog.com/p/is-transgender-identity-really-declining
[256]
Is transgender identity really declining among young adults?
Oct 16, 2025 · Earlier this week, a new report found that the number of young Americans identifying as transgender or nonbinary peaked in 2023 and has ...Missing: San Diego State
[257]
Summary of Cass Review
Apr 28, 2024 · Central to the findings is the recognition of very poor evidence for the safety and efficacy of current treatments for gender questioning ...
[258]
“Precision Medicine” and the Failed Search for Binary Brain Sex ...
Apr 10, 2025 · This paper reviews the history of failed claims about male–female brain difference in the modern era, illuminates the deep‐pocketed incentives ...
[259]
The Neuroanatomy of Transgender Identity: Mega-Analytic Findings ...
Transgender persons differed significantly from cisgender persons with respect to (sub)cortical brain volumes and surface area, but not cortical thickness.
[260]
A Retrospective Cohort Study of Transgender Adolescents' Gender ...
Jan 16, 2025 · This study found that 93% of transgender adolescents continued GAH, 2% restarted after discontinuing, and 4% discontinued without restarting, ...
[261]
Understanding and Caring for Adolescents and Young Adults Who ...
Oct 1, 2025 · The aim of this article is to examine contemporary detransition research published between 2020 and 2025 to enhance evidence-informed care for ...<|separator|>
[262]
[PDF] An Evidence-Based Critique of the Cass Review - Yale Law School
1. Evidence certainty and quality: The Review does not describe the positive outcomes of gender-affirming medical treatments for transgender youth, including ...
[263]
Looking Back on 2024 and Ahead to 2025 - SEGM
Dec 30, 2024 · We wanted to look back at this year's major developments in the field of gender medicine and look ahead to the challenges and opportunities 2025 presents.Missing: watchful waiting<|control11|><|separator|>